Covid-19 Vaccine: 12-15 Year Olds
Nadhim Zahawi Excerpts(3 years, 1 month ago)
Written StatementsRead Full debate Read Hansard Text Read Debate Ministerial Extracts
The Minister for Covid Vaccine Deployment (Nadhim Zahawi)
Her Majesty’s Government (HMG) have decided, based on advice from the Joint Committee on Vaccination and Immunisation (JCVI) and further advice from the UK Chief Medical Officers (CMOs), that a first dose of Pfizer-BioNTech covid-19 vaccine should be offered to all children and young people aged 12-15. This is the remaining group not already eligible for vaccination under earlier JCVI advice on 12-15 year olds at risk of serious outcomes from covid-19.
The JCVI advised on 3 September that for healthy 12-15 year olds the health benefits from vaccination were marginally greater than the potential known harms but that the margin of benefit, based primarily on a health perspective, was too small for the Committee to advise a universal programme of vaccination. The JCVI suggested that the Government might wish to seek further views on the wider societal and educational impacts from the CMOs of the four nations.
The CMOs worked with a range of experts including representation from the JCVI looking at this wider picture. The advice, received on 13 September, sets out that overall the view of the UK CMOs is that the additional likely benefits of reducing educational disruption, and the consequent reduction in public health harm from educational disruption, on balance provide sufficient extra advantage in addition to the marginal advantage at an individual level identified by the JCVI to recommend in favour of vaccinating this group. The CMOs recommend that on public health grounds that Ministers extend the offer of universal vaccination with a first dose of Pfizer- BioNTech covid-19 vaccine to all children and young people aged 12-15 not already covered by existing JCVI advice.
HMG has accepted this advice and all four parts of the UK expect to follow the advice and align their deployment in each nation.
For children and young people, the risk of serious outcomes from covid-19 is much lower than for older people and we recognise that decisions on vaccination for this group are therefore much more finely balanced than for adults.
All 12 to 15-year-olds will now be offered a first dose of Pfizer-BNT162b2 vaccine. The JCVI will be asked to consider in due course whether a second dose is appropriate taking into account emerging international evidence. This is in addition to the existing offer of two doses of vaccine to 12 to 15 year-olds who are in ‘at-risk’ groups as described in Public Health England’s Green Book, last updated on 3 September 2021.
I am now updating the House on the liabilities HMG has taken on in relation to further vaccine deployment to this group via this statement and a Departmental Minute containing a description of the liability undertaken. The agreement to provide indemnity with deployment of further doses to the population increases the statutory contingent liability of the covid-19 vaccination programme for the vaccine the JCVI has recommended should be used in those aged under 18, the Pfizer/BioNTech vaccine.
Deployment of effective vaccines to eligible groups has been and remains a key part of the Government’s strategy to manage covid-19. Willingness to accept the need for appropriate indemnities to be given to vaccine suppliers has helped to secure access to vaccines with the expected benefits to public health and the economy alike much sooner than may have been the case otherwise.
Given the exceptional circumstances we are in, and the terms on which developers have been willing to supply a covid-19 vaccine, we along with other nations have taken a broad approach to indemnification proportionate to the situation we are in.
Even though the covid-19 vaccines have been developed at pace, at no point and at no stage of development has safety been bypassed. The MHRA approval for use of the currently deployed vaccines clearly demonstrates that this vaccine has satisfied, in full, all the necessary requirements for safety, effectiveness, and quality. We are providing indemnities in the very unexpected event of any adverse reactions that could not have been foreseen through the robust checks and procedures that have been put in place.
Given the proximity between the announcement and deployment to this group, we regret that it has not been possible to provide 14 sitting days’ notice to consider these issues in advance of the planned vaccination of these groups in the UK.
I will update the House in a similar manner as and when other covid-19 vaccines or additional doses of vaccines already in use in the UK are deployed.
HM Treasury has approved the proposal.
A Departmental Minute will be laid in the House of Commons providing more detail on this contingent liability.
[HCWS287]
Health and Social Care
Nadhim Zahawi Excerpts(3 years, 1 month ago)
Ministerial CorrectionsRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Mr Mark Harper (Forest of Dean) (Con)
I listened carefully to the Minister’s answer to the Chair of the Health and Social Committee, and perhaps I may press him a little. He said that the Government have received only interim advice from the JCVI about the adult booster campaign, but this morning outside the House the Prime Minister said that the booster campaign would be going ahead and had already been approved. Have the Government received the final advice from the JCVI about the adult booster campaign, which it said could be different from its initial advice? Have the Government made a decision about the details of the adult booster campaign and whether it is indeed going ahead?
Nadhim Zahawi
I am grateful for my right hon. Friend’s important question. We have received interim advice from the Joint Committee on Vaccination and Immunisation, which we have published, and it has now received the Cov-Boost data. The interim advice was about vaccinating the most vulnerable with a booster for covid and for flu. It is advising a two-stage process, and stage one is to offer the booster vaccines to those in the old 1 to 4 cohorts plus the immunocompromised, and then to groups 5 to 9. That is the right way to proceed. We have not yet received its final advice. It could be different to the interim advice, but boosting preparations are well under way. Clearly that final advice is predicated on which vaccine delivers the highest level of protection and durability.
[Official Report, 13 September 2021, Vol. 700, c. 768.]
Letter of correction from the Minister for Covid Vaccine Deployment, the hon. Member for Stratford-on-Avon (Nadhim Zahawi):
An error has been identified in my response to my right hon. Friend the Member for Forest of Dean (Mr Harper).
The correct response should have been:
Nadhim Zahawi
I am grateful for my right hon. Friend’s important question. We have received interim advice from the Joint Committee on Vaccination and Immunisation, which we have published, and it has now received the Cov-Boost data. The interim advice was about vaccinating the most vulnerable with a booster for covid and for flu. It is advising a two-stage process, and stage one is to offer the booster vaccines to those in the old 1 to 4 cohorts plus the immunocompromised, and then to groups 5 to 9. That is the right way to proceed. As far as I am aware, we have not yet received its final advice. It could be different to the interim advice, but boosting preparations are well under way. Clearly that final advice is predicated on which vaccine delivers the highest level of protection and durability.
Covid-19: Booster Programme
Nadhim Zahawi Excerpts(3 years, 1 month ago)
Written StatementsRead Full debate Read Hansard Text Read Debate Ministerial Extracts
The Minister for Covid Vaccine Deployment (Nadhim Zahawi)
The UK’s covid-19 vaccination programme is a recognised success. As of 12 September 2021, 89% of people aged 16 and over in the UK have received one dose of a covid-19 vaccine, and 80% have had their second dose. Public Health England estimate over 143,600 hospitalisations and 108,600-116,200 deaths have been prevented to date by the vaccination programme in England to date[1].
The independent Joint Committee on Vaccination and Immunisation (JCVI) has published its advice on covid-19 booster vaccinations. Her Majesty’s Government (HMG) have accepted this advice and all four parts of the UK intend to follow the JCVI’s advice.
In JCVI’s view, the primary objective of a 2021 covid-19 booster programme is to maintain protection against severe covid-19 disease, specifically hospitalisation and deaths, over winter 2021-22. They have noted that this is exceptional advice aimed at maintaining protection in those most vulnerable, and to protect the NHS.
The JCVI’s advice is based on evidence from a number of sources, including UK data on the duration of vaccine-induced protection against severe covid-19. The Committee note that, as not enough time has passed to enable a clear understanding of the level of protection six months after completion of the primary vaccine course in all persons, extrapolation of some data has been required. Taking a precautionary position, JCVI considers that on balance, it is preferable to ensure protection is maintained at a high level throughout the winter months in adults who are more vulnerable to severe covid-19, rather than implement a booster programme too late to prevent large increases of severe covid-19 in previously double vaccinated individuals.
JCVI advises that for the 2021 covid-19 booster vaccine programme individuals who received vaccination in phase 1 of the covid-19 vaccination programme—priority groups 1-9 —should be offered a third dose covid-19 booster vaccine. This includes:
Those living in residential care homes for older adults.
All adults aged 50 years or over.
Frontline health and social care workers.
All those aged 16 to 49 years with underlying health conditions that put them at higher risk of severe covid-19—as set out in the Green Book—and adult carers.
Adult household contacts of immunosuppressed individuals.
As most younger adults will only have received their second covid-19 vaccine dose in late summer or early autumn, the benefits of booster vaccination in this group will be considered at a later time when more information is available. In general, younger, healthy individuals may be expected to generate stronger vaccine-induced immune responses from primary course vaccination compared to older individuals. Pending further evidence otherwise, booster doses in this population may not be required in the near term. JCVI will review data as they emerge and consider further advice at the appropriate time on booster vaccinations in younger adult age groups, children aged 12-16 years with underlying health conditions, and women who are pregnant.
JCVI advises that the booster vaccine dose is offered no earlier than six months after completion of the primary vaccine course, and that the booster programme should be deployed in the same order as during phase 1, with operational flexibility exercised where appropriate to maximise delivery. Persons vaccinated early during phase 1 will have completed their primary course approximately six months ago. Therefore, it would be appropriate for the booster vaccine programme to begin in September 2021, as soon as is operationally practicable.
JCVI advises a preference for the Pfizer vaccine to be offered as the third booster dose irrespective of which product was used in the primary schedule. There is good evidence that the Pfizer vaccine is well tolerated as a third dose and will provide a strong booster response.
Alternatively, individuals may be offered a half dose (50pg) of the Moderna vaccine, which should be well tolerated and is also likely to provide a strong booster response. A half dose (50pg) of Moderna vaccine is advised over a full dose due to the levels of reactogenicity seen following boosting with a full dose within the CoV-Boost trial.
Where mRNA vaccines cannot be offered e.g. due to contraindication, vaccination with AstraZeneca vaccine may be considered for those who received AstraZeneca vaccine in the primary course.
With deployment of booster vaccines imminent, I am now updating the House on the liabilities HMG has taken on in relation to further vaccine supply via this statement and a Departmental Minute containing a description of the liability undertaken. The agreement to provide indemnity with deployment of further doses to the population increases the statutory contingent liability of the covid-19 vaccination programme.
Given the proximity between receiving JCVI advice and deployment, we regret that it has not been possible to provide 14 sitting days’ notice to consider these issues in advance of the planned booster vaccination in the UK.
Deployment of effective vaccines to eligible groups has been and remains a key part of the Government’s strategy to manage covid-19. Willingness to accept the need for appropriate indemnities to be given to vaccine suppliers has helped to secure access to vaccines with the expected benefits to public health and the economy alike much sooner than may have been the case otherwise.
Given the exceptional circumstances we are in, and the terms on which developers have been willing to supply a covid-19 vaccine, we along with other nations have taken a broad approach to indemnification proportionate to the situation we are in.
Even though the covid-19 vaccines have been developed at pace, at no point and at no stage of development has safety been bypassed. The MHRA approval for use of the currently deployed vaccines clearly demonstrates that these vaccines have satisfied, in full, all the necessary requirements for safety, effectiveness, and quality. We are providing indemnities in the very unexpected event of any adverse reactions that could not have been foreseen through the robust checks and procedures that have been put in place.
I will update the House in a similar manner as and when other covid-19 vaccines or additional doses of vaccines already in use in the UK are deployed.
HM Treasury has approved the proposal.
A Departmental Minute will be laid in the House of Commons providing more detail on this contingent liability.
[1] PHE covid-19 vaccine surveillance report: 9 September 2021: https://www.gov.uk/government/publications/covid-19-vaccine-surveillance-report
[HCWS288]
Covid-19 Vaccinations: 12 to 15-year-olds
Nadhim Zahawi Excerpts(3 years, 1 month ago)
Commons ChamberRead Full debate Read Hansard Text Watch Debate Read Debate Ministerial Extracts
The Minister for Covid Vaccine Deployment (Nadhim Zahawi)
I am grateful, Mr Speaker. With your permission, I would like to make a statement on our vaccination programme against covid-19.
We know that vaccinations are our best defence against the virus. Our jabs have already prevented over 112,000 deaths, more than 143,000 hospitalisations and over 24 million infections. They have built a vast wall of defence for the British people.
Earlier this year, the Medicines and Healthcare products Regulatory Agency approved the covid-19 vaccines supplied by Pfizer and Moderna for 12 to 17-year-olds. It confirmed that both vaccines are safe and effective for this age group. Following that decision, the Joint Committee on Vaccination and Immunisation recommended vaccination for all 16 and 17-year-olds and for 12 to 15-year-olds with serious underlying health conditions. It next looked at whether we should extend our offer of vaccination to all 12 to 15-year-olds, which would have brought us into line with what is already happening in countries such as France, Spain, Italy, Israel and the United States of America. It concluded that there are health benefits of vaccinating this cohort, although they are finely balanced.
It was never in the JCVI’s remit to consider the wider impacts of vaccinations, such as the benefits for children in education or the mental health benefits that come from people knowing that they are protected from this deadly virus. It therefore advised that the Government may wish to seek further views on those wider impacts from the United Kingdom’s chief medical officers. The Secretary of State, together with the Health Ministers from the devolved nations, accepted that advice. Our CMOs consulted with clinical experts and public health professionals from across the United Kingdom, such as the Royal College of Paediatrics and Child Health. They have also benefited from having data from the United States of America, Canada and Israel, where vaccines have already been offered to children aged 12 to 15 years old.
Early this morning, we received advice from the chief medical officers, along with our counterparts in Scotland, Wales and Northern Ireland. We have made that advice publicly available and deposited it in the Library at 2 pm today. The unanimous recommendation of the United Kingdom’s chief medical officers is to make a universal offer of one dose of the Pfizer vaccine to the 12 to 15-year-old age group, with further JCVI guidance needed before any decision on a second dose. They have been clear that they are making this recommendation on the basis of the benefits to children alone, and not on the benefits to adults or wider society. I can confirm that the Government have accepted the recommendation. We will now move with the same sense of urgency that we have had at every point in our vaccination programme.
As the chief medical officers reminded us today, whatever decision teenagers and parents take, they must be supported and not stigmatised in any way. We must continue to respect individual choice. As a father, the decisions that I take on behalf of my own children give me extra pause for thought. People who would not think twice about getting the jab for themselves will naturally have more questions when it comes to vaccinating their children. I completely understand that, but to those who remain undecided I want to say this: the MHRA is the best medical regulator in the world, and it has rigorously reviewed the safety of our vaccines and concluded that they are safe for 12 to 15-year-olds. We continue to have a comprehensive safety surveillance strategy in place across all age groups to monitor the safety of all the covid-19 vaccines that are approved for use in the United Kingdom.
It is important to remember that our teenagers have shown great public spirit at every point during this pandemic. They have stuck to the rules so that lives could be saved and people kept safe, and they have been some of the most enthusiastic proponents of vaccines. That is at least in part because they have experienced the damage that comes with outbreaks of covid-19. More than half of 16 and 17-year-olds across the United Kingdom have had the jab since becoming eligible just last month.
At every point in our vaccination programme, we have been guided by the best clinical advice. The advice that we have received from the four chief medical officers today sets out their view that 12 to 15-year-olds will benefit from vaccination against covid-19. We will follow that advice and continue on that vital path, which is making more and more people in this country safe. I commend this statement to the House.
Jonathan Ashworth (Leicester South) (Lab/Co-op)
I am grateful to the Minister for advance sight of his statement. On behalf of the Opposition, I welcome the guidance today from the chief medical officers and the response of the Government tonight.
Children may not have been the face of this crisis but they have been among its biggest victims. Children have lost months in in-person learning, and have spent weeks cut off from friends and family. We still do not fully understand the long-term mental health implications of this, especially in poorer areas where deprivation already has widespread consequences for the health and wellbeing of our children. Being in school is not just about learning; children often access health services through school as well. I therefore particularly welcome the CMOs’ recognition of the importance of avoiding the disruption of being out of school in making this decision. We are also pleased that the Government have now made the decision, given that other nations have been vaccinating children for some months.
But many of our constituents will rightly have questions. Will the Minister explain to the House what the next stage in the children’s vaccination programme will look like? By what date does he anticipate that children will be vaccinated? On the roll-out, he will know that, for TB, HPV and children’s flu vaccinations in primary schools, it is often school nurses, health visitors and specialist vaccination teams who go to schools directly and vaccinate. Will that model be used in this case, or will children instead be asked to go to the vaccine hubs run by primary care because it is the Pfizer vaccine? Will it be the responsibility of the parents to arrange their child’s vaccination, or will the local NHS arrange it with schools, year group by year group, or class by class? Will the flu vaccine that is to be expanded to secondary school children this year be delivered at the same time as the covid vaccine, or at a separate time?
The Minister rightly said that vaccinating children is a benefit to those children but will also reduce transmission, and in that respect it is a benefit to wider society, but children and young people, and society itself, will in turn benefit if we drive up vaccination rates among adults. In the most deprived areas, fewer than 70% of the adult population are vaccinated; in the least deprived areas it is more than 90%. Among 25 to 30-year-olds, 55% are on their second dose; among 30 to 35-year-olds, 68% are on their second dose; and among 35 to 39-year-olds, 75% are on their second dose. What will he do to drive up vaccination rates among adults, because that is key to pushing down overall infection rates?
Of course, parents will want information. In the past, the Minister has suggested that this vaccination will not go ahead without the consent of parents, but he will know that the Gillick competence principle suggests that a child under 16 can consent to their treatment if the child is believed to have the understanding and intelligence to appreciate what is involved. Can he confirm what the Government’s position is in rolling out this vaccination and whether the consent of parents is necessary? In the past, he has said that it is necessary, as has the Secretary of State for Education; the CMOs seemed to suggest something else today at the press briefing.
There is nothing more precious for a parent than their child. We therefore support the approach of the Government today and welcome the advice and the recommendations of the chief medical officers. However, I hope the Minister will understand that parents, in coming to this decision, will want all the information they can possibly get hold of, and I hope the Government provide it.
Nadhim Zahawi
I am grateful to the right hon. Gentleman for his support, for his points about guidance to the parents and of course to the children, and for his points about the long-term mental health consequences of this pandemic for school-age children.
I can confirm to the right hon. Gentleman that the NHS—it is incredibly efficient and well-equipped, because it has been running the school age vaccination programme for many, many years for other vaccines—will be the primary vaccination infrastructure that we will use to deliver this vaccine. If there are schools where that is unable to be delivered, we will use the rest of the covid vaccine infrastructure, including vaccination centres, to deliver that in a safe and appropriate way. My point is to reassure him and parents up and down the country that it will be the school age vaccination programme that has run in schools. Teachers and parents are well-versed in that process.
The right hon. Gentleman asked about vaccine uptake. He will recall that I said at this Dispatch Box on 13 February, in launching the vaccine uptake programme, that the NHS continued to put effort and resource into making vaccines available and easily accessible to the most deprived communities and to all ethnic groups. We will continue to redouble our efforts, including with the booster programme, which will come later this month. We have had the interim advice from the JCVI on boosting for flu and covid. The uptake of both should increase the uptake in those communities. We have spent a lot of time looking at that.
The right hon. Gentleman asked an important question about the consent process, and I want to spend a little time on that. As with all vaccinations for children, parental consent will be sought. The consent process will be handled by each school in its usual way and will provide sufficient time for parents to provide their consent. Children aged 12 to 15 will also be provided with information, usually in the form of a leaflet for their own use and to share and discuss with their parents prior to the date of immunisation and the scheduled time for it. Parental, guardian or carer consent will be sought by the school age immunisation providers prior to vaccination, in line with other school vaccination programmes.
In the rare event that a parent does not consent, but the teenager wants to have the vaccine, there is a process by which the school age vaccination clinicians discuss this with initially the parent and the child to see whether they can reach consensus. If not, and the child is deemed to be Gillick competent, the vaccine will take place. That is very rare, but on the whole this is something that the NHS is very well versed in delivering for other vaccination programmes.
Jeremy Hunt (South West Surrey) (Con)
This is an incredibly sensitive decision but, in an open society, the Government have done exactly the right thing, which is to be open. The narrow health benefits to children are marginal, but the broader health and social benefits are considerable. Most importantly, this is one of the last pieces of the jigsaw if we are going to be able to say we have done everything possible to stop another winter lockdown. However, the final piece of that jigsaw, learning from Israel, is to have booster jabs. Could the Minister tell the House when we will have a decision on boosters? Could he also confirm that we will have no problems with supply after the Valneva decision today and with flu jabs, if we are going to have this big expansion of jabbing later in the autumn?
Nadhim Zahawi
I am grateful to my right hon. Friend for his important question. He is right to identify that this is a sensitive issue, which is why it was right for the Joint Committee on Vaccination and Immunisation to take its time to look at the data from other countries on first doses and second doses and for the chief medical officers to then do the work unimpeded which they needed to do. It is right that we follow their advice tonight.
On the booster campaign, we have received the interim advice from the Joint Committee on Vaccination and Immunisation—it was published on 30 June this year— on a potential booster programme, including flu and covid vaccine. I can reassure my right hon. Friend that the decision on Valneva will not impact our booster vaccination programme. We await the final advice. The JCVI has received the data from the COV-Boost study, where we looked at all the different vaccine brands—in some instances, full doses and half doses—as to which is the best vaccine to boost with.
I assure him that later this month we will begin a major booster programme. On flu—of course, the flu programme has already begun, and I assure him that we have the supplies for a major programme for both—we are looking at the really ambitious number of 35 million and, when we get the final advice from JCVI, the booster programme will be equally ambitious.
Dr Philippa Whitford (Central Ayrshire) (SNP)
I, too, welcome the decision to vaccinate 12 to 15-year-olds. Scotland’s NHS is also primed to deliver vaccinations as quickly as possible, but it is a pity that there was a delay and that the opportunity to vaccinate during the summer holidays was missed. In Scotland, where our schools went back before English schools, we have seen a huge surge, and we are seeing the same rise in Northern Ireland and Wales. That may happen here as well. I wonder how much of the delay was down to the remit given to the JCVI, which seemed to focus on hospitalisation and death—quite rare, thankfully, among children—rather than considering the wider impacts of education and socialisation loss or of long covid, which we are seeing in young people and children. Was the delay about the remit? Was the JCVI given a narrow remit? Or was it about whether Pfizer and Moderna vaccines would be sufficient to allow the group to have been vaccinated in the summer?
There are rumours that there will be a U-turn tonight on yesterday’s U-turn on vaccine passports. I would be grateful for the Minister clarifying that. Whether that is the case or not, this chaos undermines public health messaging, creates confusion among the public and creates rejection of whatever decision finally comes.
Nadhim Zahawi
The hon. Lady asked a number of questions that I will try to address in order. She asked about the JCVI’s remit, which was very much around what it is clinically qualified to address. That is why it advised that the CMOs needed to look at the wider impact on children specifically. There was no issue at all around shortage of vaccines, and I am confident that we have the vaccine supply that we need for both this recommendation, which we are accepting, and the booster campaign.
It was important that the JCVI took its time and looked at both first-dose and second-dose data on the rare signal around myocarditis and pericarditis. The United Kingdom has sometimes been an outlier to other nations, but on the whole we have got these decisions right because we rely on that expert clinical advice. I hope that gives reassurance to families up and down the country.
On vaccine passports, the Secretary of State for Health made it clear that we will not go ahead with vaccine certification for nightclubs or other venues. No one—certainly not on the Government side—would have moved forward with that happily. [Interruption.] If we are to have a grown-up debate, it is important for the whole House to remember that the virus is still with us and that we all want the same thing: to transition it from pandemic to endemic status so that we can have a sustainable return to normality as quickly as possible.
Dr Caroline Johnson (Sleaford and North Hykeham) (Con)
I have given many vaccines in my time, including hundreds of covid vaccines more recently, but I am not comfortable with vaccinating teenagers to prevent educational disruption. Under the current rules, no child needs to isolate if they are a contact. They do so only if they are a positive case and, for them, the maximum is eight days of schooling—and that is only if they catch coronavirus during term time. Half of children have already had it and are very unlikely to get it again. Does the Minister therefore really believe that vaccinating 3 million children to prevent an average of four days or less off school is reasonable?
Nadhim Zahawi
I am grateful for my hon. Friend’s important question, and I thank her for the work she has done and continues to do on the vaccination programme. All I would say to her is that I think it is important that the Government accept the final decision—the unanimous decision—of the four chief medical officers for England, Scotland, Wales and Northern Ireland, and offer the vaccine. Of course, parental consent will be sought, but it is only right that we offer the one-dose vaccine to 12 to 15-year-olds as per the advice received today.
Florence Eshalomi (Vauxhall) (Lab/Co-op)
I thank the Minister for the statement. I have highlighted many times in this Chamber the low take-up among some communities, specifically our black and minority ethnic communities. They are the same communities that will be hesitant about their children coming forward. They will be the same communities, if the vaccines have to be administered in school, that will make sure their children do not go to school that day. So I want to know what additional support and information—in different languages and reaching out to those communities—there will be to properly inform them so that they can make the decision about whether or not their children are vaccinated.
Nadhim Zahawi
I am grateful for the hon. Lady’s question. Actually, on her final sentence about proper information, I think it is important not to stigmatise any parent whatsoever. It is right that we supply the information, and there will be an extensive information programme that the school-age vaccination team will deliver and work on with schools. The Minister for School Standards, who is sitting on my left, and his team, whom I have to commend, have been engaged throughout today in making sure that that information does get through to parents to make that decision.
Robert Halfon (Harlow) (Con)
Given the earlier decision of the JCVI, the low risk to children and the fact that children are not significant vectors of transmitting this awful disease, will my hon. Friend ensure that the chief medical officer makes it very clear to parents who may be concerned about vaccinating their children why this needs to happen and what difference it will make to their children? The Secretary of State for Education has said that parental consent would “always”—always—be asked before they receive the vaccine, and I just want the Minister to clear that up because understandably, and rightly in my view, parents will want to be able to consent. Finally, could I ask him how much this will cost financially?
Nadhim Zahawi
I am grateful to the Chair of the Education Committee, who has rightly been incredibly engaged in the process and the debate around it. I confirm to him that parents will be asked for their consent, and information will be made available to enable them fully to understand the recommendation of the chief medical officers for England, Wales, Scotland and Northern Ireland. I will happily write to him about the cost of this part of the vaccination programme.
Andy Slaughter (Hammersmith) (Lab)
The Minister is right to say that the virus is still with us. This morning, there were 91 people hospitalised in my local hospital trust compared with 25 on 1 June, and vaccination for 16-year-olds and above—double vaccination—remains stubbornly stuck at 50% in my local authority area. Apart from this measure, what does the Minister have in mind to address these serious issues?
Nadhim Zahawi
I am grateful for the hon. Member’s question. He raises an important issue, and he has raised it with me in the MPs briefings as well. One thing we continue to do is to have the evergreen offer so that people can come forward at any time. I can share with the House that in the past week, for example, in the first phase of groups 1 to 9—the most vulnerable as per the JCVI recommendation, as the House will recall—we still had 30,000 people come forward for their first dose, and out of the second phase of groups 10 to 12, we had 70,000. Therefore 100,000 people took advantage of the evergreen offer. As we embark—the planning is well under way—on the booster programme, we continue to drive up the evergreen offer for first-dose people to come forward.
The shadow Secretary of State mentioned his experience in his constituency and in his region about the drive to increase uptake among different ethnic groups. That continues to be our priority, and we continue to make sure that those communities get not just the information but access to the vaccines. We are making it as easy as possible for them to access the vaccine without an appointment: they can just walk in and get their jab.
Mr Mark Harper (Forest of Dean) (Con)
I listened carefully to the Minister’s answer to the Chair of the Health and Social Committee, and perhaps I may press him a little. He said that the Government have received only interim advice from the JCVI about the adult booster campaign, but this morning outside the House the Prime Minister said that the booster campaign would be going ahead and had already been approved. Have the Government received the final advice from the JCVI about the adult booster campaign, which it said could be different from its initial advice? Have the Government made a decision about the details of the adult booster campaign and whether it is indeed going ahead?
Nadhim Zahawi
I am grateful for my right hon. Friend’s important question. We have received interim advice from the Joint Committee on Vaccination and Immunisation, which we have published, and it has now received the Cov-Boost data. The interim advice was about vaccinating the most vulnerable with a booster for covid and for flu. It is advising a two-stage process, and stage one is to offer the booster vaccines to those in the old 1 to 4 cohorts plus the immunocompromised, and then to groups 5 to 9. That is the right way to proceed. We have not yet received its final advice.[Official Report, 14 September 2021, Vol. 700, c. 8MC.] It could be different to the interim advice, but boosting preparations are well under way. Clearly that final advice is predicated on which vaccine delivers the highest level of protection and durability.
Mr Toby Perkins (Chesterfield) (Lab)
I have great sympathy for the Minister for having to come here to try to respond to the latest musings from the Prime Minister’s mind. I believe he is saying that when this morning the Prime Minister said that the programme was going ahead, the final advice had not been received and, indeed, while preparations are ongoing, there may be subsequent advice that once again changes everything. Is that what the Minister is saying? How does he expect people to have confidence when the information coming from the Government appears to be so arbitrary and constantly changing, with no real clarity or medical robustness to it at all?
Nadhim Zahawi
I am grateful for the hon. Gentleman’s question, although I think there is an inherent unfairness in his final few words. The whole House, indeed the nation, would agree that this virus and pandemic have been challenging not just for this country and Government, but for the rest of the world. We have had to learn rapidly about the virus and how it behaves in the human body, and there has been the incredible work of the scientists who developed the vaccine, the NHS and everyone involved in the vaccine roll-out. The interim advice is important and has allowed us to have preparations well under way to deliver the covid booster programme. I am confident that the final advice, depending on the COV-Boost study, will allow us to boost the programme this month, and boost at scale.
Dr Liam Fox (North Somerset) (Con)
Who will be responsible for writing to give advice to medical professionals on the risk-benefit analysis of giving a relatively new vaccine to 12-year-olds? Will that be the Chief Medical Officer, or the JCVI? How will the Government ensure timely and well-explained advice to parents, who will be the first point of contact and who may feel anxious about giving advice for which they are not properly qualified?
Nadhim Zahawi
My right hon. Friend raises a really important question. Of course, it was the CMOs who led the further work that took place and who made the announcement today. Health is devolved, as he knows, so the chief medical officer for Scotland will take that on in ensuring that the system—whether it is primary care or other parts of the system—understands the advice in full. The school-age vaccination programme is the major element of this particular part of the vaccination programme. It is very well versed in working with parents and teachers, and of course with young people to make sure that they have all the information they need to be able to take it back to their parents, get the consent and get their vaccination on time.
Sammy Wilson
Thank you, Madam Deputy Speaker. Not too many people pretend to be me—not even in my own party.
I find the Minister’s statement rather bizarre. First, the main medical reason given for the decision is not to protect young people from covid but to protect their mental health, their educational wellbeing and their ability to associate in society. Does he accept, first, that the way this measure will be rolled out could lead to children being bullied, stigmatised and named on Instagram, Twitter and so on, because the whole school will know whether they go for a vaccine or not, and secondly, given that school principals can make the decision whether a group of individuals, a class or a year group is closed down if people are found to have tested positive in the school, that this is no guarantee that educational disadvantage will not be attacked either?
Nadhim Zahawi
I am grateful for the right hon. Member’s question. Actually, quite the opposite is the case. First, he will know that school bubbles have gone. The school-age vaccination programme and those clinicians are really very well equipped and very well versed in dealing with vaccines in schools, so this will not be a new thing for them. Their ability to gain consent and communicate exactly why the chief medical officers have gone ahead is, in my view, an important element of the decision to accept the recommendation tonight. So I would say quite the opposite: it is right that we accept the recommendation tonight.
As I said in my statement, no one—no parent or child—should be stigmatised for making a decision. We have been transparent all the way through this process, and we have been incredibly careful, as we have demonstrated. Many other countries now boast that their vaccination programmes have reached far higher numbers than ours. I have always said that this is not a race; it is about doing the right thing for children and adults to transition this virus from pandemic to endemic.
Sir Iain Duncan Smith (Chingford and Woodford Green) (Con)
I welcome my hon. Friend’s statement, but I want to return to the issue of where the children will make this decision. The reality is that we have parents taking responsibility for their children, and at the end of the day we say we are going to ask them whether or not they give responsibility for their child on this matter. However, where there is a dispute, we say that the school will decide whether or not that child has the capacity to make that decision. This is the point: the pressure will grow on the child. There is no way of legislating for this greater good concept that says, “The school may be in trouble, and your class may be in deep difficulty, if you do not take the vaccine.” I simply say to my hon. Friend that this is a real problem for us. It will lead to disputes in families and real problems about children’s mental health in the opposite direction, as they are put under pressure. I wonder whether he and the Government will think again about this. Without serious, clear guidance, it will lead to children being in a worse state than they would have been without the vaccine.
Nadhim Zahawi
I am grateful for my right hon. Friend’s really important question. I want to spend a few seconds explaining this to the House, because it is really important. He mentioned that the decision would lead to teachers having to explain; actually, it is quite the opposite. It is not the teacher’s responsibility to do that; it is a qualified clinician’s. The school-age vaccination programme is very well equipped to do that in a discreet and careful way with parents and with the child. However, that will be on very rare occasions; the bulk of vaccinations will be conducted only if there is parental consent.
Rachael Maskell (York Central) (Lab/Co-op)
It is really important that every parent has access to a supported conversation—we know that that is a very positive public health intervention—but it is important for every young person too, because they also want to be equipped with information. I see the Minister nodding. In light of that, and not just one new vaccine programme but a second one, can he explain the resourcing of staff to not only vaccinate but provide that information? In addition, can he explain why 11-year-olds are being excluded? Our secondary system runs from 11 upwards, as opposed to 12.
Nadhim Zahawi
Our regulator has only regulated the vaccines for 12 to 15-year-olds. I reiterate the point that the school-age vaccination programme and the infra-structure we have is very well versed in delivering vaccines and gaining consent. Of course, the NHS in England—the same is happening in Scotland, Wales and Northern Ireland—has been thinking through exactly how the communication, the comms and the leaflets, will be provided to parents so that they have the information necessary to be able to make the decision for their child to be vaccinated.
Sir Graham Brady (Altrincham and Sale West) (Con)
The Minister praised JCVI, quite rightly, but it is clear from the advice it gave recently that what was weighing most heavily on its mind was the lack of long-term evidence about the possible adverse reactions due to myocarditis following vaccination. As it said just 10 days ago:
“substantial uncertainty remains regarding the health risks associated with these adverse events.”
What has happened in the last 10 days to remove that uncertainty?
Nadhim Zahawi
The important thing to remember is that the JCVI’s advice was very much predicated on what it was clinically qualified to look at. It was its recommendation to the chief medical officers to then take a further look. My hon. Friend will recall that JCVI’s advice was that, on balance, it is beneficial for children to have the vaccine rather than not have the vaccine, but not enough to recommend a universal programme, hence its advice to CMOs to go further on that. The work the CMOs have done in recommending a single dose is very much predicated on the data they have seen. JCVI, by the way, were in the room during the deliberations from America and elsewhere on the myocarditis on the second dose.
Mr Kevan Jones (North Durham) (Lab)
I welcome the statement from the Minister tonight. I agree with my right hon. Friend the Member for Leicester South (Jonathan Ashworth) when he says that clear information will be key. I would just suggest that social media might be more effective with young people rather than leaflets. May I raise an issue around children with special educational needs? Some may already have been vaccinated because of vulnerabilities. Will the Minister outline what arrangements have been put in place for schools and cohorts of individual children with special educational needs? It will need a lot more effort and time to ensure we get them vaccinated.
Nadhim Zahawi
The right hon. Gentleman is quite right. A number of children with special educational needs would have been vaccinated already, because they would have come under the earlier JCVI recommendation. The school-age vaccination programme does pay particular and careful consideration to those schools, working with school leaders and making sure that parents are able to get all the information. I mentioned leaflets earlier, but of course there will be a digital information programme as well.
Miriam Cates (Penistone and Stocksbridge) (Con)
Given the known and unknown risks of vaccinating healthy children, and given that between 40% and 70% of children are estimated already to have covid antibodies, what plans does my hon. Friend have to offer antibody testing to children so that parents can make an informed decision about whether vaccination may be in their child’s best interests?
Nadhim Zahawi
I am grateful for my hon. Friend’s important question. As we now accept the recommendation from the chief medical officers of England, Wales, Scotland and Northern Ireland, it is also right for us to look at the question that she raised. I will happily write back to her after this statement.
Munira Wilson (Twickenham) (LD)
The Minister will be aware that some estimates suggest that a staggering 900 million days of face-to-face schooling have been lost since the start of the pandemic. In that context, I welcome the Government’s decision today, but children’s vaccination is only one part of the puzzle—so are improved ventilation, funding for air purifiers in classrooms and, in some crowded environments, continuing with face coverings. Given that two Department for Education Ministers are sitting on the Front Bench alongside him—the Minister for School Standards, the right hon. Member for Bognor Regis and Littlehampton (Nick Gibb) and the Under-Secretary of State for Education, the hon. Member for Chelmsford (Vicky Ford)—will he press his colleagues to provide that funding for schools so that they can remain open safely for as many children as possible? Will the Government give us a cast-iron guarantee that we will not see any school closures this winter?
Nadhim Zahawi
I am grateful for the hon. Lady’s support for tonight’s decision. The Department for Education is rolling out, I think, 300,000 carbon dioxide monitors. It is very important that ventilation is very much part of what we do as we transition this virus from pandemic to endemic status.
Tim Loughton (East Worthing and Shoreham) (Con)
May I come back to the issue of parental consent and, in doing so, declare my entry in the Register of Members’ Financial Interests? I welcome the fact that this will be done with parental consent, because all the pressures would be far greater if it were left up to individual children, with all the peer pressure and stigma that that could bring. Will the Minister tell us what the situation will be for children in care? Will the default position be, as corporate parents, that all children in the care system will be vaccinated? What then happens if the birth parent or the long-term foster carer has an objection to that?
Nadhim Zahawi
I thank my hon. Friend for his important question. The deemed carer for that child will be requested to give that consent.
Jon Trickett (Hemsworth) (Lab)
Is it not clear, first, that many other countries have been vaccinating this age range for some time; secondly, that school classes have been engines for transmission; and thirdly, that this is not in the end a medical decision, but about wider social welfare? That has been plain for some time, well before the school holidays. In those circumstances, the timing of this announcement is odd. Given the fact that prevarication, delay and hesitation, which the Government have been guilty of, can simply lead to further transmission, is this not a bit late?
Nadhim Zahawi
I hope I addressed that question earlier. I think quite the opposite, and the reason I say that is that it is right that the Joint Committee on Vaccination and Immunisation has taken its time. It has looked at data from other countries that proceeded with this vaccination programme and has looked at data not just on first dose, but on second dose, which has only recently been made available. It is much better to be careful than to proceed with a vaccination programme in a way that may not be appropriate. We have some of the best clinical advice in the world. It is only right that we listen to that and proceed as carefully as we can as we transition this virus from pandemic to endemic.
Mr Steve Baker (Wycombe) (Con)
Just returning to stigmatisation, will the Minister guarantee that a child’s ability to receive an education equally with their peers will never be linked to their vaccination status?
Nadhim Zahawi
My hon. Friend asks a really important question around vaccination status. I can certainly say to him that that will not be used in any way. The whole purpose of this is to accept the clinical advice and to protect children. It was remiss of me, in response to an earlier question, not to say that the CMOs looked very specifically at the mental health and other implications for the child, not for the rest of society.
Olivia Blake (Sheffield, Hallam) (Lab)
Is the Minister concerned that some children’s hospitals are seeing winter levels of respiratory syncytial virus, another virus that affects young children? What will he do to ensure that those who are clinically extremely vulnerable are continually monitored so that they can access the flu vaccine and the covid vaccine in a timely manner without overlap?
Nadhim Zahawi
That is a matter that we spend a lot of time on, and I know that the NHS and school-age vaccination programmes have been working hard on it. We have operationalised flu vaccination, but the other vaccines, as the hon. Lady quite rightly reminds the House, are equally important for children’s health.
Dr Julian Lewis (New Forest East) (Con)
To what extent does the vaccination of a child reduce his or her liability to transmit the virus to a vulnerable person such as an elderly grandparent?
Nadhim Zahawi
I will happily write to my right hon. Friend with the data that the JCVI and the CMOs have looked at. Suffice it to say that the data that I have looked at from the United Kingdom, where we have not embarked on a children’s vaccination programme but are about to, is that 60% of those who are double-vaccinated do not become infected with the delta variant, which is the dominant variant at the moment, and therefore cannot transmit and infect others; 40% can.
Caroline Lucas (Brighton, Pavilion) (Green)
The Minister mentioned the booster programme. Will he publish all the scientific evidence on which any wider booster plan is based? Will he consider the message that a population-wide booster programme might risk sending to other countries: the sense that everyone has to do it? We know that supplies of the vaccine are not limitless, so that could be an absolute disaster for countries in Africa, for example, where only 2% of people are fully vaccinated. Will he consider prioritising vaccines that are within their shelf life, for example, and giving them to COVAX? As he and others have said many times, none of us is safe until we all are.
Nadhim Zahawi
Just as we published the JCVI’s interim advice on 30 June, we will absolutely do the same with the final advice. We have now delivered more than 9 million doses, through COVAX or bilaterally, out of the 100 million that we planned to deliver. We went further when we received a request from our Australian colleagues: we delivered 4 million doses of the Pfizer vaccine that they needed immediately, and we can take that back when we think we need it for our booster programme. The hon. Lady quite rightly highlights the issue of vaccinating with the rest of the world, which is an important part of our work with the vaccines taskforce.
I reassure the House and families listening at home that, as far as the interim advice or any final advice allows, I am confident that we will have vaccines available to boost all those whom the JCVI recommends we should boost.
Steve Brine (Winchester) (Con)
I am deeply uncomfortable with this decision. I think that when the JCVI made a decision on the application of the vaccine on clinical grounds it was in the right place—but the Government now have the answer that they want from the experts, so we are where we are.
Parents like me and our constituents will have many, many questions asked of them by their children, probably at bedtime. What will be their route for answering those questions? Where will they get the information? Just saying that the MHRA is the best regulator in the world will not cut it with my daughter. Will people be able to have conversations with their family doctor? At the moment—let’s face it—that is quite challenging. Can the Minister guarantee that we will be able to ring up and have a real-life conversation, not with an answerphone but with our family doctor, to ask questions about the very, very big move announced today?
Nadhim Zahawi
I am grateful for my hon. Friend’s question, but I would just slightly push back. He said that the Government have the answer that we want; that is actually incorrect, because I can tell him that the Government made it very clear that the JCVI and the chief medical officers had to base their decision on the work that they do, unimpeded and unencumbered in any way, and they have made that decision today. I can reassure him that the information provided through the school-age vaccination programme infrastructure will be made available both online and as hard copy—in leaflets—so that parents have all the information that they need, as well as the ability to consent; and, of course, that information will also be available to the children.
Clive Efford (Eltham) (Lab)
I heard the Minister’s earlier answer about assistance for schools with ventilators and air purification. The time to roll that out would have been during the summer holidays, in preparation for the return to school. Yet again, we seem to be way behind the pace of what is going on. May I urge the Minister to talk to his colleague the Minister for School Standards, the right hon. Member for Bognor Regis and Littlehampton (Nick Gibb), who is sitting next to him, to get some urgency into the assistance for schools with this issue?
Nadhim Zahawi
I think it worth reminding the House that ventilation guidance has been there from the very beginning for schools and school leavers to implement, but the roll-out is happening as we speak. Our colleagues in the Department for Education are working right now to get those pieces of equipment into schools as quickly as possible.
Sir Geoffrey Clifton-Brown (The Cotswolds) (Con)
I have great respect for my hon. Friend as the vaccines Minister, but I find what he has announced this evening deeply troubling. I think it will pit parents against parents and parents against teachers, with a poor child stuck in the middle wondering what to do. There will be very little benefit to the child, and there is a lack of long-term data on the potential harm. However, what concerns me above all is that the Gillick doctrine of treating children without parental consent will become the norm for a range of medical procedures.
Nadhim Zahawi
Let me, again, slightly push back on that. It is not teachers who are being asked to do this; it is our clinicians, who are well trained and incredibly capable because they do the same thing year in, year out for the purpose of school-age vaccination programmes. They will be offering the vaccines, and ensuring that parents have enough time to read the information and then give their consent before a vaccination takes place.
This is very much not about a situation involving division. I think—I hope—my hon. Friend agrees that throughout the vaccine deployment programme that we began in earnest back on 8 December last year with Pfizer-BioNTech and continued on 4 January with the AstraZeneca vaccine, we have endeavoured never to stigmatise anyone and to provide as much information and transparency as possible, which has led to the highest level of vaccine positivity in the world. I believe that according to the Office for National Statistics data on vaccine positivity in the UK, more than 90% of adults have said that they are very likely to take the vaccine, or have already taken it.
Kate Osborne (Jarrow) (Lab)
Many children will be anxious and worried on hearing the news that they will be receiving a vaccination, and I share the concern expressed about that by a number of Members this evening. How will the Minister be working with schools and teachers to ensure that children are informed about the vaccine in an age-appropriate and sensitive way?
Nadhim Zahawi
It is important to remember that the clinicians who deliver the school-age vaccination programme around the country are very well equipped to deliver information about these vaccines, as they do in respect of others. The information will of course be made available to parents, and, as I have said, the consent procedure will be followed very closely. The infrastructure is not new; it is not something novel about which we might have to hesitate and worry. It is already there, and it is well able to deliver this programme.
Mr Marcus Fysh (Yeovil) (Con)
There is a great danger in politics that we sometimes make decisions while looking in the rear-view mirror rather than at what is truly the current picture. I have grave concerns about this policy and the fact that the chief medical officers have made their decision on the basis of the educational impact rather than the health of the children at clinical level. I disapprove of this decision incredibly strongly, and I wonder what we can we do to ensure that this kind of thing does not happen again, because I firmly believe that this is a very dark day for our country. Is it going to end with vaccinating five-year-olds when there is no clinical need? This is not about teachers or education. The virus is endemic now; there is not a pandemic any more. We have to get real, and I hope that the Government will reconsider.
Nadhim Zahawi
I remind the House that the chief medical officers looked at the mental health impact on children before making their decision today. That was an important aspect of their deliberations, and as I have said, the JCVI was in the room as well as the royal colleges. It is also important to remind the House that vaccination will be voluntary, and that no parent or child should be stigmatised in any way. As with our vaccination programme, this is about making all the information available and letting people make their mind up as to whether they want their child to be vaccinated.
Jim Shannon (Strangford) (DUP)
Can the Minister confirm that, as with all medical decisions for under 16-year-olds, the decision will always lie with the parent or the person with parental responsibility, and not with the child? Will the Minister state clearly for all to hear that this Government will continue to embrace autonomy and not enforce mandatory vaccination at any time, as has been done in communist regimes to the detriment of freedom and democracy?
Nadhim Zahawi
I remind the hon. Gentleman of the answers I gave earlier on consent. Parental consent will be sought, and the school-age vaccination programme is very well equipped to do that. The consent process is being handled by each school in its usual way and will provide sufficient time for parents to provide their consent. Children aged 12 to 15 will also be provided with information, usually in the form of a leaflet, for their own use and to share and discuss with their parents. The consent of the parent, guardian or carer will be sought by the school. In the rare circumstances in which a parent withholds consent but the child wants to be vaccinated, the child has to be deemed competent by the clinicians after consultation between the child and the parent. If that consultation is unsuccessful, the child has to be deemed to be Gillick competent. That has been the law of the land for other vaccination programmes, and in those circumstances the vaccination would proceed.
Richard Fuller (North East Bedfordshire) (Con)
My hon. Friend has again cited Gillick competence as a reason why parental consent can be overridden, but many people will think that this situation is very different from the fundamental basis of the Gillick competence. This is a widespread programme with all the issues of pressure and peer pressure that may arise from it, and we have had only a few months to understand the implications of this vaccine for people’s health. Also, the Minister himself has said that there is not much evidence on the long-term implications. Can he advise the House what legal assessment he has undertaken to support the Gillick competence in this case?
Nadhim Zahawi
The Government have taken copious legal advice on this issue. I remind the House that on the rare occasions when there is a difference of opinion and a parent withholds consent when their child wants to be vaccinated, the clinician will bring together in consultation the child and the parents to try to reach consensus before they move on to the question of Gillick competence.
Greg Smith (Buckingham) (Con)
Following the answer that my hon. Friend the Minister gave to my hon. Friend the Member for Wycombe (Mr Baker) earlier, could he outline the concrete steps that the Government will be taking, particularly within educational settings but also in wider society, to guarantee that no unvaccinated child will be treated any differently from a vaccinated one?
Nadhim Zahawi
There will be no question of discriminating in any way between vaccinated and unvaccinated children. Vaccinations are voluntary and will remain so.
Chris Green (Bolton West) (Con)
My hon. Friend acknowledges there is a small hazard with the vaccine programme, which is why there is one jab for these younger children. Will he confirm that all families will have access to their trusted family GP to get advice and understanding on the hazards before they are expected to make a decision on this important matter?
Nadhim Zahawi
The best way for parents and families to make that decision is through the tried and tested process of the school age vaccination programme, and through schools sharing information and having a consent form that parents have to sign and return before the vaccination programme is scheduled.
Madam Deputy Speaker (Dame Rosie Winterton)
I thank the Minister for his statement.
Covid-19: Immunology Research
Nadhim Zahawi Excerpts(3 years, 1 month ago)
Westminster HallRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Westminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
The Minister for Covid Vaccine Deployment (Nadhim Zahawi)
Thank you very much, Dr Huq. It is a pleasure to be here, in person, to serve under your chairship. I thank the hon. Member for Strangford (Jim Shannon) for securing this debate, and of course the hon. Members for Tooting (Dr Allin-Khan) and for Airdrie and Shotts (Anum Qaisar-Javed).
The shadow Minister referred to Edward Jenner and Blossom, and of course we all owe a huge debt of gratitude to Dame Sarah Gilbert, who now has a Barbie from Mattel in her image. I hope that will encourage many young kids to take up science, as a number of us in this Chamber have done. As I am sure colleagues here know, I am a proud chemical engineer from University College London. I think it appropriate, on a day like this, to congratulate the behind-the-scenes group—as the shadow Minister referred to them—of incredible scientists, whose incredible work has allowed us to deal with this pandemic. I am sure the whole House would want to join me in that.
I also congratulate Sir Shankar Balasubramanian and Sir David Klenerman. They have just received the $3 million Breakthrough Prize, which is referred to as the “Oscars of science” for their work at Cambridge on next-generation genome sequencing. To bring that to life for the House, it took $3 billion and about 10 years to sequence the first human genome. Their work on next-generation genome sequencing now allows that same work to take an hour and about $1,000, which makes a real contribution to future discovery.
For those who do not know her, I would also encourage people to look at the work of Professor Katalin Karikó, who has also been awarded the Breakthrough Prize today. She is not from the United Kingdom, but has had to travel a long journey, from Hungary to the USA and the University of Pennsylvania. Her personal struggle and her work on mRNA allowed BioNTech and Moderna, using her patents, to develop those incredible vaccines.
By calling this debate, the hon. Member for Strangford has really provided us with an opportunity to discuss the world-leading contributions that UK researchers have made by increasing our ability to tackle this disease. Investment by the Government has assisted the science underpinning the development of many of the tools we need to harness to ultimately defeat this virus.
UK-based research has provided insights that are crucial to improving surveillance, patient care and management, and developing new diagnostics, therapies and vaccines. Identifying how the immune system responds to covid-19 is critical to understanding so many of the unknowns around this novel virus. For example, why does it make some people sick and not others? What constitutes effective immunity and how long might that immunity last?
The immune system is extremely complex. To make rapid and effective progress in our knowledge, a nationally co-ordinated approach was needed, as the hon. Member for Strangford referred to. That is why £6.5 million of funding has been provided from UK Research and Innovation and the National Institute for Health Research to the UK Coronavirus Immunology Consortium. The UK is world leading in the quality of its immunology research, and this innovative project has enabled us in Government to commission at pace the research needed to understand the immunology of covid-19, and as a result successfully deliver real benefits to patients and public health. The key themes identified by UK-CIC included the understanding of primary immunity, and describing the body’s immune response to covid-19 and how this might explain the different risks presented by the virus to individuals. In other words, why do some get sicker than others?
What constitutes protective immunity? Identifying how an effective immune response can be generated and how it can be maintained to prevent re-infection was essential for the development of effective vaccines and understanding why some people remain vulnerable even after vaccination. Unpicking the mechanism of the disease caused by immunopathology—how the body’s own immune response to the virus can cause damage to tissues and organs, and how that can be stopped—is essential knowledge for the development of effective treatments, along with identifying immune vaccine evasion and how the virus might evade the body’s protective immune response through natural infection or vaccination, leaving people vulnerable to re-infection.
I want to highlight some further research that we have commissioned and funded in the field of diagnostics. The COVID-19 National DiagnOstic Research and Evaluation Platform—the CONDOR study—is accelerating how quickly promising diagnostics make it out of the lab and into real-world use. This will support the diagnosis of infection and the management of patients with suspected covid-19, which is important for the subsequent waves of infection in the post-pandemic setting.
On vaccine development and deployment, we all know the benefits that both doses of the vaccine can bring to many people. Indeed, colleagues have mentioned that today. Data from Public Health England suggests that two doses of the covid vaccine offer protection against hospitalisation of around 96%. The United Kingdom has been at the forefront of vaccine development, helped by the investment that we have made in this vital research. The ChAdOx1 vaccine platform—already shown to be safe and effective through a previously funded phase 1 trial against the middle east respiratory syndrome, or MERS, which the hon. Member for Strangford rightly referred to in his speech—was quickly adapted to develop a vaccine candidate against covid-19 and launched human trials in April 2020.
In parallel, project funding was also provided to investigate and develop more efficient vaccine manufacturing processes, enabling vaccines to be made more rapidly. However, the development of an effective vaccine is just the first step, and I commend the efforts of the NHS in the world-class roll-out of the vaccine programme among adults and young people across our four nations. Our efforts in understanding why some people do not develop a protective response even after receiving two doses of the vaccine are an important next step in our research portfolio, hence the Government have commissioned important studies to understand vaccine responses among the most vulnerable in our society.
However, despite the success of the current vaccination campaign, we are doing more by investing in research that will inform us about how to deliver vaccinations in the future and to help us to understand why some immunosuppressed people are not fully protected. I regularly meet charities that support clinically extremely vulnerable patients, and I share their concerns about the risks to this group from contracting covid-19.
There is a breadth of research activity being funded in order to look at vaccine response in immunocompromised individuals. The OCTAVE—observational cohort trial T cells antibodies and vaccine efficacy in SARS-CoV-2—study is examining covid-19 vaccine responses in clinically at-risk groups, including patients with certain immunosuppressed conditions. Building on the work that we did with the OCTAVE trial, we are funding OCTAVE DUO, which is a new clinical trial to determine whether a third dose of a vaccine will improve the immune response in people who have weakened immune systems. Additionally, the UKRI-funded research to be commissioned following the recent research on vaccine immune failure will investigate the strength and durability of the immune response, which I know colleagues are interested in understanding better in a wide range of people, including those with conditions that result in a weakened immune system, such as HIV.
The development of novel treatments for covid-19 has been made possible by the work and funding that we have provided for immunology research. As referred to by a number of hon. Members, that includes the UKRI and NIHR-funded projects looking at the immune response generated during infection with covid-19, which revealed that the body produces harmful immune responses that attack its own tissues and organs. That leads to severe disease and may underlie some forms of long covid, but further research is needed to better understand this. Research of this type has helped the development of new and effective treatment options, including the recently approved novel monoclonal antibody treatment Ronapreve. This novel treatment development was also supported by a UKRI and NIHR-funded trial.
I will briefly turn to some of the questions that hon. Members asked. The hon. Member for Strangford asked about long covid, which can have very serious and debilitating long-term effects for thousands of people across the UK. It can make daily life extremely challenging. We are providing significant funding for several studies in order to better understand the long covid problem, improve diagnosis and find new treatments. In July, the Department provided just shy of £20 million—I think it was £19.6 million—of funding towards an extensive programme of 15 new research studies, which will allow researchers across the UK to draw together their expertise from analysing long covid among people suffering long-term effects and the health and care professionals supporting them. The projects will better understand the condition and how to identify it, evaluate the effectiveness of different care services on people with long covid, identify effective treatments, such as drugs and rehabilitation, to treat people suffering from long covid, and improve home monitoring, which is a key issue.
Jim Shannon
I am very encouraged by that. Is it the intention of the Minister’s Department to share the results of those studies with all the different regions of the United Kingdom, so that we can all benefit? As health matters are devolved, the evidential base and final conclusion of the studies will be very important for us all.
Nadhim Zahawi
I completely share the hon. Gentleman’s concerns about that issue, and it is important that we look at it very seriously. He also asked whether we have enough supply of monoclonal antibody treatments. I can tell him that the regulatory approval and clinical policy will provide information on which patients could benefit from the treatments and how much supply is needed. We are working with the companies to ensure that we have a supply of those products in the coming months. Which patients are likely to have access to those treatments? Again, the NHS England antibody expert group is currently designing clinical guidance on how the NHS should use the treatments, which includes defining and identifying the eligible patient cohorts that are likely to benefit following a positive covid test.
In terms of deploying the treatments, part of the work of the NHS England expert group is on the clinical guidance on identifying potential deployment in hospital and possible pathways, especially through clinics and at-home services following a positive test. The hon. Gentleman also asked what research is looking at long-term immune response in individuals who are vaccinated. The Department is funding a number of important studies into immune response: the SARS-CoV-2 immunity and reinfection evaluation, or SIREN, study in healthcare workers; the Vivaldi study in care home residents and workers; and the coronavirus infection survey led by the Office for National Statistics, with repeat household visits looking at who has antibodies to covid from either vaccination or previous infection.
The hon. Gentleman asked about vaccine manufacturing in the longer term. I can tell him that in 2018, UKRI announced £66 million for the UK’s first dedicated vaccine manufacturing and innovation centre, VMIC. The goal was to promote, develop and accelerate the growth of the UK vaccine industry. When the pandemic began, UKRI reacted at unparalleled scale and speed to ensure that all investments were ready and able to respond to the challenge, and that they were plugged in to the UK’s wider vaccine, life science and pharmaceutical ecosystem. An additional £131 million was made available as an investment in, I think, May 2020, bringing the total for VMIC to just shy of £200 million, at £196 million. VMIC will be able to deliver about 200 million doses of vaccine, of any technology, at scale per annum, so it is a big investment.
The hon. Gentleman also asked what the Government are doing to support the development, production and procurement of vaccines for the future. As well as VMIC, we are planning for all scenarios in the fight against covid and its variants. Some of the recent analysis supports our understanding that both the Pfizer BioNTech and AstraZeneca vaccines currently being deployed in the UK appear to work well against the current dominant variants of covid, and continuing to administer those vaccines at scale remains our key to bringing the virus under control.
We are also assessing our existing portfolio against current variants, working closely with vaccine manufacturers and Public Health England, to understand the efficacy of our portfolio. We think we are in a good place vis-à-vis the interim advice from JCVI on the booster campaign, which we hope to begin later this month.
Finally, the hon. Gentleman asked whether there was any existing research that had helped to accelerate the development of vaccines. He quite rightly cited the work of the Oxford team, but even before the covid-19 pandemic, they were already doing that research because of funding from UKRI—and thank goodness for that.
To conclude, I fully recognise the tremendous impact that the pandemic has had on so many people. Commissioning high-quality immunology research is an essential part of our armoury in fighting this virus. We will continue to implement research findings and, at the same time, commission and fund new projects that will deepen our understanding of the disease and identify further defences that will keep us safe. Throughout this pandemic, the Government have been there to support and invest in research. As we shift our focus from the initial impact of the pandemic, we intend to continue to provide funding and support for covid-19 research, underlining precisely why the UK has long been, and continues to be, a great place for world-leading research and researchers.
Dr Rupa Huq (in the Chair)
Finally, in this debate where all hon. Members have demonstrated quality, if not quantity, I call Jim Shannon to wind up.
Health and Social Care
Nadhim Zahawi Excerpts(3 years, 1 month ago)
Ministerial CorrectionsRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Nadhim Zahawi
On 19 July, the Prime Minister announced that
“by the end of September—when all over 18s will have had the chance to be double jabbed—we are planning to make full vaccination the condition of entry to nightclubs and other venues where large crowds gather. Proof of a negative test will no longer be sufficient.”
We will be confirming more details in due course.
[Official Report, 8 September 2021, Vol. 700, c. 305.]
Letter of correction from the Minister for Covid Vaccine Deployment, the hon. Member for Stratford-on-Avon (Nadhim Zahawi).
An error has been identified in my speech.
The correct statement should have been:
Nadhim Zahawi
On 19 July, the Prime Minister announced that the Government were planning that
“by the end of September—when all over 18s will have had the chance to be double jabbed—we are planning to make full vaccination the condition of entry to nightclubs and other venues where large crowds gather. Proof of a negative test will no longer be sufficient.”
We will be setting out more details in due course.
Covid Vaccine Passports
Nadhim Zahawi Excerpts(3 years, 1 month ago)
Commons ChamberRead Full debate Read Hansard Text Watch Debate Read Debate Ministerial Extracts
Urgent Questions are proposed each morning by backbench MPs, and up to two may be selected each day by the Speaker. Chosen Urgent Questions are announced 30 minutes before Parliament sits each day.
Each Urgent Question requires a Government Minister to give a response on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
Mr Alistair Carmichael (Orkney and Shetland) (LD)
(Urgent Question): To ask the Minister for the Cabinet Office, if he will make a statement on the Government plans for covid vaccine passports.
The Minister for Covid Vaccine Deployment (Nadhim Zahawi)
Our vaccination programme has given this nation a wall of protection against this deadly virus. Data from Public Health England estimates that two doses of a covid-19 vaccine offers protection of around 96% against hospitalisation and that our jabs have prevented over 100,000 deaths, over 143,000 hospitalisations and around 24 million infections. It is this protection that allowed us to carefully ease restrictions over the past few months. However, we must do so in a way that is mindful of the benefits that both doses of the vaccine can bring.
On 19 July, the Prime Minister announced that
“by the end of September—when all over 18s will have had the chance to be double jabbed—we are planning to make full vaccination the condition of entry to nightclubs and other venues where large crowds gather. Proof of a negative test will no longer be sufficient.”
We will be confirming more details in due course.[Official Report, 9 September 2021, Vol. 700, c. 4MC.]
This approach is designed to reduce transmission and serious illness. It is in line with the approach we have taken on international travel, where different rules apply depending on whether someone has had both jabs.
I would like to end by urging people to come forward to get the jab. Some 88% of people have had one jab and more than 80% of people aged 16 and over have now had the protection of both doses. It is the best way to protect yourself, your loved ones and your community, so please come forward and join them, and make our wall of protection even stronger.
Mr Carmichael
First, thank you, Mr Speaker, for allowing me to ask this urgent question; as Big Brother Watch brings its campaign against vaccine passports to Westminster today, it is certainly timely.
The introduction of vaccine passports will have enormous practical implications for the literally thousands of businesses across the country that will be required to gather and to hold our data. It is on those aspects that the answers are most urgently required from the Government—this must not be “in due course”, as the Minister has just said. The deadline for the implementation of this scheme is now just three weeks away. We must not, however, lose sight of the fact that a scheme of this sort opens the door to a major change in the relationship between the citizen and the state. Never before in peacetime have a Government in this country controlled, in this way, where we can go and with whom, and what to do. If the Government have concluded that this now has to change, at the very least this House must have a chance to make its voice heard and its views known. So when will we get the vote that the Minister promised us before the recess?
The case for vaccine passports is riddled with inconsistencies. Nightclubs have been open since July and, notwithstanding recent events in Aberdeen, they have been relatively safe. If they are safe today for people to enjoy responsibly, what do the Government expect to change between now and the end of the month? On Monday the Minister told me at the Dispatch Box:
“We do know that 60% of people who have had two jabs will not become infected with the Delta variant and therefore cannot infect someone else, although 40% will and can.”—[Official Report, 6 September 2021; Vol. 700, c. 75.]
The 40% figure highlights one of the biggest dangers of the whole idea: taking people into large social gatherings where they think they will be safe from infection but in fact they are not. The Minister will know that there will always be some who cannot be vaccinated, so if entry to nightclubs or events is to be dependent on demonstrating vaccination, those people will be excluded. So can he tell the House: what assessment have the Government done with regard to their duties under equalities legislation? A study by the Night Time Industries Association found that 69% of its members view the introduction of vaccine passports as having a negative impact on business, and 70% said they were not necessary for opening their business. Why are the Government not listening to the experts in the industry? When will nightclubs and other businesses be told how will they be expected to check the vaccine status of their patrons? What legal authority will they have to do that and what will the consequences be for them if they do not do it?
On 12 July, the Secretary of State for Health and Social Care told the House:
“As we move away from regulations, there will no longer be a legal requirement for any establishment to have covid vaccine certification”.—[Official Report, 12 July 2021; Vol. 699, c. 32.]
When did that change and why?
Nadhim Zahawi
I am grateful for the right hon. Gentleman’s questions and I will attempt to address them. I will begin by saying to the House that no one in this Government, and certainly not this Prime Minister—it is not in his DNA—wants to curtail people’s freedoms or require people to show a piece of paper before they enter a nightclub. The reason we are moving forward on this is that we have looked at what has happened in other countries, where nightclubs were opening and then shutting again, and opening and then shutting again, and we want to avoid that disruption and maintain sectors that can add to people’s enjoyment of life and dance, as was the case for the Chancellor of the Duchy of Lancaster. We want them to be able to do that sustainably.
The reason behind the end of September date, which the right hon. Gentleman asked about, is that by then all 18-year-olds and above will have had the chance to have two doses.
The right hon. Gentleman was quite right when he quoted what I said to him at the Dispatch Box a few days ago: 60% of people who are doubled vaccinated will not be infected and therefore will not spread the infection, but 40% may do. The view of our clinical experts is that the additional relative safety of people having to be doubled vaccinated before they can enter a nightclub does begin to mitigate super-spreader events, which could cause us, in effect, to take a decision to close nightclubs, which we would not want to do.
The right hon. Gentleman asked about the disruption to business; as he will know, this is a tried and tested solution that has been used extensively throughout the Government’s events research programme. It requires venues to check or scan the NHS covid pass, in the same way as nightclub bouncers check ID before entry.
The right hon. Gentleman asked about the equality impact assessment. I assure him that we conducted a full equality impact assessment and consulted widely to understand the potential equality impact of covid status certification. We spoke to ethicists and representatives of disabilities, race and faith groups. The system allows both digital and non-digital proofs, to help to ensure access for all. Constituents who do not have a smartphone, for example, can confirm their vaccine status by calling 119 and getting proof via email or written letter.
As I say, this is not something we do lightly; it is something to allow us to transition this virus from pandemic to endemic status. We are coming towards the winter months, when there will be upward pressure of infections because of the return to school and winter. Large gatherings of people, especially in indoor venues such as nightclubs, could add to that. The mitigation against that, to allow us to transition the virus from pandemic to endemic status, is the booster programme that I hope we will embark upon later this month, after the final recommendations from the Joint Committee on Vaccination and Immunisation.
Mr William Wragg (Hazel Grove) (Con)
What a load of rubbish. I do not believe that my hon. Friend believes a word he just uttered, because I remember him stating very persuasively my position, which we shared at the time, that this measure would be discriminatory. Yet he is sent to the Dispatch Box to defend the indefensible. We in this House seem prepared to have a needless fight over this issue. It is completely unnecessary. We all agree that people should be encouraged to have the vaccine, and I again encourage everybody to do so, but to go down this route, which is overtly discriminatory, will be utterly damaging to the fabric of society.
Nadhim Zahawi
I am grateful to my hon. Friend, who has made his view clear to me on many occasions. It pains me to have to take a step like this, which we do not take lightly, but the flipside to that is that if we do not and the virus causes super-spreader events in nightclubs and I have to stand at the Dispatch Box and announce to the House that we have to close the sector, that would be much more painful to me.
Angela Rayner (Ashton-under-Lyne) (Lab)
I thank the right hon. Member for Orkney and Shetland (Mr Carmichael) for bringing this important topic to the House.
I associate myself with the Minister’s opening remarks regarding vaccine uptake. It is incredibly important that people take up the vaccine where possible, and I reiterate that from the Opposition Dispatch Box.
We are weeks away from implementation, but while Ministers were relaxing over the summer, there was no clarity from the Government about these plans. Businesses remain anxious. Our priorities are clear: to protect the NHS and our economy. We absolutely cannot be faced with an unmanageable winter crisis for both. My first question to the Minister is really simple: what does he think this will achieve? How and when will the UK Government decide which businesses must implement vaccine certification, and will they rely on low-paid staff at venues to act as public health officials, and what support will they be getting?
The NHS covid pass application currently allows individuals in England to either input a negative test result or complete a vaccine record. That is important for those who cannot, for legitimate medical reasons, take the vaccine. Will the Minister explain why the Government plan to drop the negative test option? Will they improve and keep available the NHS covid pass application or will it be replaced or outsourced?
Let me be crystal clear: we cannot support any potential covid pass scheme for access to everyday services. Can the Minister categorically assure me that no one will be required to have a covid vaccination pass to access essential services?
This Government have dithered, dawdled, and, as some have said, dad danced away the summer. They have not planned or prepared, and they have not provided the reassurances or presented a clear path forward. UK businesses have had a hell of an 18 months during this difficult pandemic. They need a proactive, supportive Government, and it is about time that Ministers worked towards that aim.
Nadhim Zahawi
I am grateful to the hon. Lady for her opening words and for urging those who have not had a vaccine to come forward and be protected. She asked a number of important questions relating to this measure, including what it will achieve. She will know that double vaccination was important for people to be able to travel, and the implementation of that was largely successful. We need to go further to make sure that we recognise other vaccines from other countries around the world. Those vaccines need to be recognised by the WHO, our regulator and other regulators to make it even easier for people who are double vaccinated to travel to the United Kingdom. The NHS in England, Scotland, Wales and Northern Ireland stands ready to continue that joint work, as does NHSX in terms of the technology.
The hon. Lady asked about people’s access to essential settings, which is incredibly important. I can assure her that some essential services will not require people to show covid vaccine certification. They include settings that have stayed open throughout the pandemic, such as public sector buildings, essential retail, essential services and, of course, public transport.
She also asked what certification will achieve domestically. I hope that, combined with the vaccination programme, the booster programme and all the work that we have done around education, we will be able to transition this virus, post winter, from pandemic to endemic status. The reason for this very difficult decision is that it allows us to sustain the opening of the economy, including the nightclub sector, without having to flip-flop, go backwards and close down sectors because of super-spreader events. The chief medical officer, Chris Whitty, tells us that in absolute terms. As I said earlier, if people are double jabbed, only 60% will not be infected by the virus and therefore not spread it, but 40% could be infected. In relative terms, putting that downward pressure on infection rates is important in that journey towards transition from pandemic to endemic.
Mr Mark Harper (Forest of Dean) (Con)
I have to say that I agree with the Chairman of the Public Administration and Constitutional Affairs Committee, my hon. Friend the Member for Hazel Grove (Mr Wragg). The Minister set out earlier this year that this policy was discriminatory. He was right then and that remains the case. It is a discriminatory policy. The vaccines are fantastically effective at reducing hospitalisation and death. They are very much less effective in reducing transmission of the Delta variant. This is a pointless policy with damaging effects. I am afraid that the Minister is picking an unnecessary fight with his own colleagues. I say to him that the Government should think again. The Leader of the House has been clear that we do not believe—the Government do not believe—that this policy is necessary for us to meet here in a crowded place. Let us not have one rule for Members of Parliament and another rule for everybody else. Drop this policy.
Nadhim Zahawi
My right hon. Friend asks about my previous position. I addressed it a few days ago from this Dispatch Box. Back in January and February, we did not have the level of evidence on the Delta variant, which he mentioned. That variant is far more infectious—it requires only a few particles of Delta for a person to be infectious. Let me repeat the data that I cited earlier: 60% of people who are double vaccinated will not be infected by Delta and therefore will not spread it, but 40% could be infected and then spread it.
As for the policy being discriminatory, there will, of course, be exemptions—for example, in exceptional circumstances where a clinician recommends vaccine deferral, where that vaccine is not appropriate, and where testing is also not recommended on clinical grounds. Then there are those who have received a trial vaccine, including those who have been blinded or given a placebo as part of the formally approved covid vaccine trials in the United Kingdom.
This is not something that we enter into lightly, but it is part of our armoury to help us transition over the winter months from pandemic to endemic status. I hope to be able to stand at this Dispatch Box very soon after that and be able to share with the House that we do not need to do this any more as we will be dealing with the virus through an annual vaccination programme.
Stewart Hosie (Dundee East) (SNP)
I pay tribute to all those involved in the vaccination programme. It has been extraordinary. In Scotland, we have 4.1 million adults with a first dose and almost 4 million with a second dose, which means that north of 90% of all adults have had at least one dose. It is a fantastic result across the UK since last December, but the pandemic is not over. Lives are still at risk and the pressures on the NHS are very real, so we in Scotland are introducing a vaccine passport, but, broadly, it will be limited to nightclubs, outdoor standing events with more than 4,000 people and any event with more than 10,000 people. While the rules in England may be slightly different, I hope that they are as proportionate as that.
May I go back to the issue of essential services? It is not enough simply to say that a person will not need a vaccine passport to get an essential service. It has to be any setting where a person’s attendance is unavoidable—shops, public transport, medical services and education. We need the confirmation that no setting where a person’s attendance is unavoidable will require a vaccine passport.
Nadhim Zahawi
I am grateful to the hon. Gentleman for his excellent citation of the vaccine success in Scotland. NHS Scotland has done a tremendous job, as has the NHS in Wales, Northern Ireland and, of course, England. He raises an important point about essential services. In the process of parliamentary engagement and scrutiny, we will be able to share the detail of that in due course.
Karen Bradley (Staffordshire Moorlands) (Con)
I pay tribute to my hon. Friend the Minister, who is defending a policy that I do not think his heart is truly in. May I ask him a technical question? If a fake vaccine passport is used, who will bear responsibility? Will it be the venue, the person who checked it, or the individual who used the fake passport? Who will police it? Will we be asking our local police, our local authority or some other agency?
Nadhim Zahawi
My right hon. Friend asks an important question. When I or a Minister from the Cabinet Office stands at the Dispatch Box and shares the detail of the implementation, we will address that issue in full.
Seema Malhotra (Feltham and Heston) (Lab/Co-op)
The Night Time Industries Association and others have expressed concerns about the practical implementation of this policy. As the Minister has highlighted, those questions remain and need to be answered quickly. Will the Minister also publish clear guidance on which events and venues will require a covid passport? There will also be increased costs for businesses at a time when they are recovering, so will they also be getting extra funding, and when will that be announced?
Nadhim Zahawi
Absolutely, we will issue clear guidance about venues. Nightclubs are a particular concern when it comes to evidence from other countries of super-spreader events, but, absolutely, we will do that.
Sir Desmond Swayne (New Forest West) (Con)
Isn’t the super-spreader event the spread of illiberal, discriminatory and coercive policies from this Dispatch Box?
Nadhim Zahawi
It pains me to have to stand at the Dispatch Box and implement something that goes against the DNA of this Minister and his Prime Minister, but we are living through difficult and unprecedented times. As one of the major economies of the world, our four nations have done an incredible job of implementing the vaccination programme. This is a precautionary measure to ensure that we can sustainably maintain the opening of all sectors of the economy.
Munira Wilson (Twickenham) (LD)
I almost feel sorry for the Minister because he really is struggling to defend this policy. However, he has failed to answer the fundamental question posed by my right hon. Friend the Member for Orkney and Shetland (Mr Carmichael) about this deeply illiberal, discriminatory and unnecessary policy: will this House get a vote on the implementation of covid vaccine passports—yes or no?
Nadhim Zahawi
There will be appropriate parliamentary scrutiny, as I have said today and in the past.
Karl MᶜCartney (Lincoln) (Con)
I fear that my hon. Friend is on a sticky wicket. Let me point out to him that, if people have had covid but have not had any vaccinations, they will not get the passport that he is proposing and therefore will not be allowed into nightclubs. We are a proud, liberal party in that we believe in freedoms; whatever happened to a laissez-faire attitude? Nightclubs have been open since July. My hon. Friend has not closed them yet. There is no need for a vaccine passport.
Nadhim Zahawi
That is an important question. My hon. Friend is quite right that nightclubs have been open since July. The end of September date was chosen deliberately to allow over-18s to have the opportunity to be double vaccinated. On people who may have had covid and not had the vaccine, there is evidence—for example, on the beta variant—that it can be much more harmful to people unless they get vaccinated. I urge people who have had covid and recovered to get the vaccine, get double jabbed and get protected.
Mr Speaker
Let us hear from the former voice of the DJs of the north—Jeff Smith.
Jeff Smith (Manchester, Withington) (Lab)
Thank you, Mr Speaker. As somebody who worked in nightclubs for 25-plus years, let me tell the Minister that this is a recipe for chaos on the doors of nightclubs. As my hon. Friend the Member for Feltham and Heston (Seema Malhotra) said—and as I said to the Minister the other day—the Night Time Industries Association has said that this will cripple the industry. This industry has been massively hard hit and it relies on walk-up trade; this is going make it impossible for nightclubs to run.
Let me ask the Minister two questions. First, how does he define a nightclub, as opposed to a late bar with a DJ playing music? Secondly, there is no rationale for this—as the hon. Member for Lincoln (Karl MᶜCartney) said, nightclubs have been open for weeks—so why close them now? Why require vaccine passport for nightclubs, as opposed to other crowded indoor venues, such as the Chamber and the voting Lobby of the House of Commons?
Nadhim Zahawi
That is an important question. As I said earlier, part of the trials gave us the confidence that we can do this and do it well. These passports have already been implemented for international travel and other countries in Europe have them for nightclubs. We think this is the right thing to do to help us transition the virus from pandemic to endemic status. We will be coming forward with the details for parliamentary scrutiny in due course.
Nadhim Zahawi
I agree with my hon. Friend that there is a very strong libertarian argument and not one with which I would disagree. This is a difficult and important decision. As he says, we are still not in a place where I can stand here and say, hand on heart, that we have transitioned this virus and that it is no longer a pandemic. That is why we are having to take this decision. I slightly disagree with his latter point; public buildings should obviously remain accessible and open to all without these passports, because there are relative measures that we can take to allow us the additional protection as we head towards the booster programme.
Chris Bryant (Rhondda) (Lab)
Mr Speaker, I am feeling sheepish about earlier; my apologies—touché.
This is just nonsense. I am 100% in favour of vaccination and 100% opposed to vaccine passports. There is no legal definition of what a nightclub is, as opposed to a place where other people might be bouncing up and down, and shouting at one another across a Chamber in a room of 500 people. There is no legal definition that the Minister is going to be able to rely on. The Government will effectively be turning bouncers on the door into legal officers, who will be deciding whether somebody has had a placebo or not. This is for the birds. We can relieve the Minister of all his pain; he just has to say that he has thought again and he is not going to do it.
Nadhim Zahawi
I am grateful to the hon. Member for his question. Bouncers will not have to decide if someone has had a placebo or not, because anyone who has been on a trial will be deemed to be vaccinated and will receive their certificate.
Nadhim Zahawi
I said this at the Dispatch Box before recess. Actually, the Secretary of State took to the World Health Organisation a plea to the rest of the world that people in trials should be considered fully vaccinated, whether they have had the placebo or otherwise, in order to encourage them to come forward for vaccine trials. I repeated that today. It will not be an issue for nightclub bouncers.
Richard Fuller (North East Bedfordshire) (Con)
The measures presented by the Minister today are unsupportable because they are bereft of any rationale. I ask him to think carefully about whether this Government wish to take powers that were deemed to be emergency powers and make them the normal powers of a Government in a free society. I, for one, think that that is extremely unwise and that there is no case for this.
Nadhim Zahawi
I agree with my hon. Friend that the times that we are enduring are not normal. This is a measure that we are having to take. As he will hear from our chief medical officers in England, Scotland, Wales and Northern Ireland, this is a mitigation to allow us to continue to transition this pandemic over the winter months and not have to reverse our policies. I say, with a heavy heart, that I would much rather stand here and take from colleagues arrows in the back—or in the front—than come back to this House and have to close down nightclubs because the virus has caused a super-spreader event. I do not want to have to explain that to the whole industry, because it would be much more detrimental to businesses to have to open and shut them, and open and shut them again.
Emma Hardy (Kingston upon Hull West and Hessle) (Lab)
The Minister cannot underestimate how much freedom has been limited for those with medical exemptions. I have heard from some of my constituents that they feared even leaving the house. The idea that they will see those freedoms limited again is abhorrent, so how can the Minister ensure that the medically exempt will not have further restrictions on their freedoms because of his vaccine passport plan?
Nadhim Zahawi
We have spent a lot of time, energy and resource on ensuring that those with medical exemptions, who have underlying medical conditions, were prioritised in both category 4 and 6 of phase 1 of the vaccination programme, as the hon. Member will recall. The Joint Committee on Vaccination and Immunisation has gone further for the immunosuppressed. As I said earlier, there will be exemptions from this particular set of rules for people who, for whatever reason, cannot be vaccinated or cannot have a test for medical conditions.
Chris Green (Bolton West) (Con)
Will my hon. Friend confirm that the duration of these passports, whether they are passed by the Government or it is done by a vote, would only last as long as it is considered that the United Kingdom was in a pandemic state, not an endemic state, in terms of the disease? Will he also set out when that transition happens so that we can judge and understand it for ourselves?
Nadhim Zahawi
I am grateful for my hon. Friend’s thoughtful question. There is great difficulty with knowing at what stage we feel confident that the virus has transitioned from pandemic to endemic. We have now entered a period of equilibrium with the virus because of the success of the vaccination programme. The upward pressure on infections is obviously schools going back. The downward pressure on infections will be the booster programme and mitigating policies like the one we are debating. The Government certainly do not see this as a long-term power grab to restrict people’s liberties.
Florence Eshalomi (Vauxhall) (Lab/Co-op)
I feel I should try to help the Minister by thanking him for the regular briefings on vaccination uptake over the recess, which was very helpful to me in terms of encouraging a number of people from the BME communities to take up the vaccine. However, this policy is not going to work in Vauxhall. A number of businesses that have been hampered over the last 18 months want to get back. A number of those businesses are fearful of the looming rent increases for private commercial tenants. A number of businesses are fearful about the backlog of business rates that they have to pay. We are now probably going to ask those same businesses to pay to implement this policy. I want to go back to the issue raised by my hon. Friend the Member for Feltham and Heston (Seema Malhotra): what funding will be available to those businesses and when will they receive it?
Nadhim Zahawi
I am grateful for the hon. Lady’s kind words about the engagement that we have maintained throughout the vaccine deployment programme. We will continue to do so, by the way, as we enter the booster programme, which, in some weeks, will hopefully break all records that we set in phase 1 of the vaccination programme. I think what is more detrimental to businesses in Vauxhall is having to open and shut, and open and shut again. The reason for this policy is to sustain their ability to trade, and hopefully trade profitably.
Miss Sarah Dines (Derbyshire Dales) (Con)
I think we all agree that vaccine take-up among the young is essential. What additional incentives can you offer the young people I work with on Hurst Farm, a social housing estate in Matlock, to take up the vaccine?
Nadhim Zahawi
Young people have been coming forward in droves to be vaccinated. We have walk-in centres all around the country where people do not even have to book an appointment. There have been many different ideas for incentivisation of young people. The great incentive, I hope, is to protect themselves, their families and their community, but also to enjoy the freedoms that come with double vaccination.
Mr Speaker
Can I just say that I will not be giving any incentives? When the hon. Lady said “you”, it meant me, and I definitely do not want to do that.
John Spellar (Warley) (Lab)
As the Minister has indicated, many countries are already introducing checks in hospitality and entertainment venues, and a large number of our own citizens are visiting them on holiday, showing vaccine passes issued free by Her Majesty’s Government and having already undergone checks at airports. I have been arguing since February for the introduction of vaccine passes in order to save venues and jobs. To ensure that they can stay open, will he now cut through the hysteria and get on with it?
Jason McCartney (Colne Valley) (Con)
On Sunday, I joined dozens of volunteers for a thank you event with Medicare Pharmacy for the 58,000 jabs that it has delivered to local people this year. What more, though, can the Minister do to encourage—I stress the word “encourage”—those who are still to have their jab to come forward and do so?
Nadhim Zahawi
I am grateful for my hon. Friend’s work. He has been a champion of the vaccination programme and I am grateful to Medicare Pharmacy. We continue to have pop-ups at universities and walk-ins around the country, and incentives to young people to get vaccinated. We also continue to redouble our efforts to keep the vaccine evergreen for those who have not yet had their first dose.
Sarah Olney (Richmond Park) (LD)
Last week, I spoke to a constituent who is a widow with four children and has been working for the NHS on the frontline throughout the pandemic. One of her children has a range of very complex needs that can only be met by full-time residential care, and there is only one setting in the entire country that can meet his particular needs. She has been told that it cannot take him because of a shortage of care staff, and that the particular difficulty in recruiting at the moment is the requirement for care staff to have had two jabs. As the right hon. Member for Forest of Dean (Mr Harper), who is no longer in his place, highlighted, the vaccine does not prevent infection or the spread of covid. So why, given the crisis in recruitment of care staff, do we still have this requirement for two jabs when it is not effective and is depriving vulnerable people of the care they need?
Nadhim Zahawi
If the hon. Lady will forgive me, I wish to reiterate that what she said is inaccurate in the sense of the vaccines not preventing infection. Sixty per cent. of people who are double-vaccinated will not be infected and therefore cannot spread the virus, but 40% can. This is an important measure. We have a duty of care to those most vulnerable in care homes in ensuring that the staff are double-jabbed, and they have until 11 November to do that.
Simon Jupp (East Devon) (Con)
Make no mistake: vaccine passports will create a two-tier society with the hospitality industry having to police an unethical policy that will hammer its recovery. Given the Government’s own words that we need to live with this virus, will my hon. Friend confirm how long vaccine passports will be in place—if passed by this House?
Nadhim Zahawi
We will set out in detail in due course exactly how the vaccine pass will work for domestic use: for example, in nightclubs.
Jim Shannon (Strangford) (DUP)
I thank the Minister for all the hard work he does and for answering these very difficult questions. It would seem that each region of the United Kingdom of Great Britain and Northern Ireland has differing versions of the system in relation to offering vaccine passports, and that confuses people whenever they read or hear it in the national news. What discussions have taken place with regional Administrations on this issue? Are there any plans to standardise each region to have a one-size-fits-all UK strategy that people can understand and follow?
Nadhim Zahawi
I am grateful for the hon. Gentleman’s excellent question. I am very proud, as are the Ministers from the devolved Administrations, of the work we have done collectively on the vaccination programme, which we will continue to do for the booster programme. As he heard earlier, this is a devolved matter but we try to co-ordinate wherever possible and do the right thing together.
Jacob Young (Redcar) (Con)
I congratulate the Minister and all those involved in the vaccination roll-out on four-fifths of over-16-year-olds now being double-vaccinated. This Government have worked night and day to ensure that we have the testing capacity to test over 1 million people a day, and many millions more with lateral flow tests as well. Surely a nightclub full of people who have tested negative is safer than a nightclub of people who are double-vaccinated.
Nadhim Zahawi
I am grateful for my hon. Friend’s championing of the vaccination programme. He raises an important point. One of the issues around lateral flow tests is the risk of people fraudulently inputting their test result, but also those are for a single excursion whereas being double-vaccinated means that people can go and enjoy nightclubs as many times as they like.
Joy Morrissey (Beaconsfield) (Con)
May I, on bended knee, implore my hon. Friend to summon all his courage and say no to vaccine passports to protect our civil liberties? He has been so courageous in the vaccine roll-out, so will he please protect our civil liberties and say no to vaccine passports?
Nadhim Zahawi
I hope that when my hon. Friend pauses and reflects on what we will be bringing forward, she will see that it is that it is much better for the nightclub industry to be able to open sustainably while we get through the next few months. The winter months are going to be tough and challenging not just for covid but also for flu. It is a far better option to listen to the clinical advice of the CMOs and implement something that is difficult for me to do, and goes against everything I believe in, but nevertheless is the right thing to do.
Greg Smith (Buckingham) (Con)
We have a whole summer’s worth of data from the events research programme that shows how organisers of events such as the British grand prix at Silverstone in my constituency had to meet extreme costs to put in the planning and the checking of vaccine passports at the gate. Before this policy is put to a vote in this House, will my hon. Friend commit to publishing the data on the cost to business of vaccine passport checks through the events research programme, so that we can be fully apprised of the cost of this policy?
Nadhim Zahawi
My hon. Friend’s question is important and is one that we will be looking at. Suffice to say, as I mentioned earlier, the events research programme certainly gave us the confidence that people can deal with this measure relatively easily. In the way that a nightclub bouncer can check ID, they can check covid vaccination status.
Holly Mumby-Croft (Scunthorpe) (Con)
Like many across the House, I am instinctively wary of this idea. Will my hon. Friend give me a clear answer to a specific question: will right hon. and hon. Members receive a vote? For the avoidance of doubt, I am talking about a vote and not scrutiny of the policy.
Nadhim Zahawi
I have said that there will be parliamentary scrutiny around this, and we will be coming back and setting out in detail what that looks like.
Christian Wakeford (Bury South) (Con)
I am flabbergasted, depressed and annoyed that we are even discussing this matter. It is absolutely wrong on a fundamental level. Putting to one side the practical implications of how it will be policed, more important are the general data protection regulation implications of bouncers having medical data in their hands. What are we doing in regard to the data? Nightclubs have been open for over two months. Is there any data to support this policy, because I do not think there is?
Nadhim Zahawi
The very strong advice from the chief medical officers—we have heard from our colleagues in Scotland, too—is that this will be an important mitigating measure. It is something we do not do lightly. I completely understand my hon. Friend’s sentiment and emotion on this. In terms of the data presented, it will be limited simply to the vaccine status and the name of the individual. It can be on a smartphone, but if someone does not have one, it will be physical or by email.
Covid-19 Update
Nadhim Zahawi Excerpts(3 years, 2 months ago)
Commons ChamberRead Full debate Read Hansard Text Watch Debate Read Debate Ministerial Extracts
The Minister for Covid Vaccine Deployment (Nadhim Zahawi)
With permission, Madam Deputy Speaker, I will update the House on covid-19 and our vaccination programme.
Earlier this summer, we took the fourth step on our road map. We were able to take that step because of our vaccines and the way that they are working. The latest data from Public Health England estimates that our jabs have prevented over 100,000 deaths, over 143,000 hospitalisations and around 24 million infections. Across the United Kingdom, we have administered over 91 million vaccines; 88.8% of people over 16 have had their first dose, and 79.8% have had their second dose. Our jabs are building a vast wall of defence for the British people.
But this vital work is not yet complete. With the delta variant sweeping around the world, we have seen how it thrives on pockets of unvaccinated people. Last week, across the UK, we saw an average of 34,000 new cases and 938 hospitalisations each day. It is vital that we continue to plug the gaps in our defences and widen and deepen our wall of defence.
Over the summer, we have continued to do that in several ways. In August, the Joint Committee on Vaccination and Immunisation recommended that vaccines should be offered to 16 and 17-year-olds. It also recommended jabs for 12 to 15-year-olds with specific underlying health conditions and household contacts of someone who is immunosuppressed. We accepted both recommend- ations, bringing us into line with countries such as Sweden. In recent weeks, 16 and 17-year-olds have been coming out to do their bit in droves, travelling with schoolmates and family members to get the jab.
We are taking the jab to people, too, with walk-in and pop-up vaccination sites at football stadiums and shopping centres, and of course at university freshers’ fairs; I think we have got to 20 universities. Over the bank holiday weekend, NHS pop-up sites at the Leeds and Reading festivals made picking up a jab as easy as getting a beer or a burger. As a result of these kinds of efforts, more than half of 16 and 17-year-olds across the United Kingdom have received their jabs since becoming eligible last month. That is in addition to over three in four—76.3%—18 to 34 year-olds, who have already had at least their first dose. Much of young people’s enthusiasm, I believe, comes from the fact that they have seen at first hand the chaos that covid-19 can bring. They have sacrificed so much and shown that age is no barrier to public spirit. I am sure the whole House will join me in thanking them for playing their part in helping us all to live safely.
On Friday, the JCVI outlined its recommendations on the vaccination of children aged 12 to 15 years who do not have underlying health conditions. It concluded that while there are benefits to vaccinating this cohort, taken purely on health terms the benefit is finely balanced. Building on the JCVI’s advice, we will now consider advice from the UK’s four chief medical officers and make a decision shortly. We have already accepted the JCVI’s recommendation that 12 to 15-year-olds with the following conditions become eligible: haematological malignancy, sickle cell disease, type 1 diabetes, congenital heart disease and poorly controlled asthma. That will amount to an extra 200,000 teens becoming eligible.
I also want to take this opportunity to address vaccination in pregnant women. The Royal College of Obstetricians and Gynaecologists and the Royal College of Midwives have both recommended vaccination as one of the best defences for pregnant women against severe covid infection. Extensive real world data show our vaccines are safe and highly effective for pregnant women. We now know that pregnant women are more likely to become seriously ill from covid if they are not vaccinated. In fact, 98% of pregnant women in hospital due to covid-19 are unvaccinated. Yet we also know that not one single pregnant woman with two jabs has required hospitalisation with covid-19. I urge pregnant women to continue to come forward and get the jab. Our new Preg-CoV trial is advancing knowledge on how we can even better protect pregnant women and their babies.
Taking all of that together, our overarching ambition is to widen our wall of defence so that we can protect more and more people. As well as widening that wall of defence, we are deepening it. Last Wednesday, 1 September, the JCVI advised that people with severely weakened immune systems should have a third vaccine dose as part of their primary covid-19 vaccination schedule. It will be offered to people over 12 who were severely immunosuppressed at the time of their first or second dose, such as those with leukaemia, advanced HIV and recent organ transplants. This, I must stress, is separate from any potential booster programme for the rest of the population. The JCVI is still investigating who should receive boosters. Our cov-boost study is comparing immune responses produced by third doses of different brands of vaccines.
Dr Luke Evans (Bosworth) (Con)
Will the Minister give way on that point?
Madam Deputy Speaker (Dame Rosie Winterton)
Order. This is a statement, so the hon. Gentleman can bob up later if he needs to.
Nadhim Zahawi
As ever, whatever the clinical decision from the JCVI, the NHS will be ready. We will proceed with the same sense of urgency we have had at every point in this campaign.
Vaccines remain our most important line of defence, yet they are not our only line of defence. Regular testing continues to play a crucial part in returning this country to something that feels a bit more like normal. PCR tests remain freely and easily available, and anybody with symptoms should make sure to get tested. Children are returning to classrooms across these islands. I am sure all hon. Members welcome that, as did the Secretary of State for Education at questions this afternoon. They return to an immeasurably better set up: no more home schooling, no more bubbles, teachers vaccinated, and all 16 and 17-year-olds offered a first dose before returning. That matters because we know that face-to-face education is the best place for children and young people.
Rapid testing can uncover hidden cases of the virus at the start of term. Whether it is our constituents or our children, we must encourage people to do it. On their return to school and colleges, students should take two rapid tests on site three to five days apart. They should then continue to test twice weekly at home. To university students, I would also say this: make every effort to get fully vaccinated before going back. It has never been easier to drop in and get a vaccine and the necessary testing. These are straightforward steps, but they are essential in stopping the spread.
Finally, I am sure the whole House will join me in welcoming the additional £5.4 billion cash injection we are putting into the NHS. This investment will go straight to the frontline, supporting our covid-19 response over the next six months. The funds include £1 billion to help to deliver routine surgery and treatments for patients, and tackle our backlog. The funds take the Government’s total support for health services in response to covid-19 to over £34 billion this year alone.
We are widening and deepening our wall of defence. We are getting jabs to more people and getting some people more jabs. We are getting the NHS what it needs. The ask of our NHS colleagues continues to be complex and challenging, yet they rise to it day in, day out. I pay tribute to everyone involved in these lifesaving efforts. We must keep going, and I commend this statement to the House.
Jonathan Ashworth (Leicester South) (Lab/Co-op)
I thank the Minister for advance sight of his statement. Like him, I praise all our NHS staff. I particularly want to associate myself with the remarks about the safety of the vaccine for pregnant women.
Children’s health and wellbeing has always been a driving priority of mine. Children may not have been the face of this pandemic, but they have certainly been among its biggest victims. The record will show that I have been asking in this House about the vaccination of adolescents for some months. I of course understand the position of the JCVI and welcome the review on the wider implications for children’s wellbeing by the chief medical officers. Should vaccination be recommended and the chief medical officers do recommend vaccination, that will command our full support on the Labour Benches. If the chief medical officers recommend vaccination, will the Minister guarantee that our public health workforce, our health visitors and our school nurses, as well as primary care, will have the resources they need to roll out that vaccination?
Children are back to school. In Leicester, children have been back in school for two weeks. In Scotland, children have been back in school for some weeks also, putting upward pressure on infection rates. If the chief medical officers recommend vaccination, how long does the Minister think it will take to roll out that vaccination? Are we talking months? Are we talking weeks? Are we talking days? If he could give us an indication, I am sure we would all be grateful. The Education Secretary has removed many of the infection control mitigations in schools. We urged Ministers to use the summer holidays to install ventilation, air filtration units and carbon dioxide monitors in schools. How many schools have now had those systems installed?
The hon. Member for Stratford-on-Avon (Nadhim Zahawi) is the Minister for vaccines. Primary and secondary school children are due to receive a flu vaccine, yet not only is the NHS apparently running out of blood test tubes, with certain vital tests delayed, but we are now told that flu vaccination will be delayed, because deliveries are delayed by two weeks, and GPs are cancelling flu vaccination appointments. This is before we head into what could be one of the most difficult winters in living memory. What will the Minister do to get a grip of this situation and avoid a flu crisis this winter? If there is a delay in flu vaccines, does he expect that to knock on to any booster jab campaign? Less than a month ago, the Health Secretary said he wanted booster jabs to be given at the same time as flu jabs and he said that they would start this month.
Finally, we of course welcome the new funding for the second half of the financial year and we welcome that it would appear that Ministers have listened to our calls for the discharge to assess funding to be extended, but I think the whole House would agree that surely one of the most heartbreaking, and in my view frankly unforgivable, episodes in the pandemic was the failure to protect care homes and to put that protective ring around care homes as we were promised. If covid has taught us anything, it is that a long-term plan for social care is long overdue and that it should be funded in a fair way. The Minister, along with every Conservative Member, was elected on a manifesto that promised a social care plan and promised no rise in national insurance. The Prime Minister guaranteed no rise in national insurance, but we are told to expect, tomorrow, a rise in national insurance—a tax on workers to pay for a regressive social care policy that simply will not improve the care that people need and deserve. In this House, the Minister used to call national insurance a “tax on jobs”. What would he call a manifesto-breaking national insurance rise now?
Nadhim Zahawi
I am grateful to the right hon. Member for his support and his words on the vaccination of pregnant women and the protection that the vaccine offers them.
On the right hon. Member’s question about the JCVI advice on 12 to 15-year-olds, the JCVI looked at the very narrow impact of the vaccine on 12 to 15-year-olds, because that is very much its remit. It also advised that the chief medical officers should take a wider look. That is what they are doing as we speak. Panels of experts from local public health as well as other experts are looking at the impact of the vaccine on mental health and the disruption to education specifically for 12 to 15-year-olds. They will come back with recommendations. The JCVI is observing those panels and is very much in the room, as far as that is concerned.
It is also worth reminding the House that the Medicines and Healthcare Products Regulatory Agency has looked at the Pfizer and Moderna vaccines and has approved both vaccines as safe and eligible to be administered to 12 to 15-year-olds. It is not worth our pre-empting the report of the chief medical officers of England, Wales, Scotland and Northern Ireland. Throughout the pandemic, we have operationalised the vaccine programme; we prepare early and we prepare well. To give the right hon. Member a direct answer to his question, the NHS is prepared to administer a vaccine within five working days of any recommendation. That does not pre-empt any recommendation. We did the same when none of the vaccines was approved. Some colleagues will recall Brigadier Phil Prosser explaining at the press conference that we had built the equivalent of the infrastructure of a national supermarket chain and were growing it by 20% every week. We have done the same thing when it comes to all outcomes of the deliberations at the JCVI and what it will ultimately recommend.
On education, the Secretary of State for Education addressed many of the issues on the mitigation and controls in schools, as well as testing and the very successful adult vaccination programme that we have delivered, which is now also delivering protection for 16 and 17-year-olds.
I really want to address the point about flu and I hope that we can have a sensible discussion on it. We are being very ambitious on flu. The interim advice from the JCVI is wherever possible to co-administer flu and covid vaccines. Traditionally, flu vaccination begins earlier—it begins now. One of the suppliers, Seqirus, has had a border issue with its Spanish fill-and-finish factory, which it has used for many, many years. This is the first time that it has had this issue. It is meeting the Spanish regulator to see what the issue is. It is being very careful and estimating a one or two-week delay. This will not delay the overall flu vaccination programme at all. Its German and Belgian supply chain has been flowing normally. It is one of the suppliers, so I urge the right hon. Gentleman not to, as a knee-jerk reaction, talk about flu vaccine shortages. We are being incredibly ambitious on flu vaccines—including procuring centrally as well as the traditional procurement through GPs and pharmacies—with a big, big programme.
Wherever possible, we will co-administer. The only caveat I would place on that is that the JCVI has given us only its interim advice on covid. We are not yet there with the cov-boost data, which it will look at. It will give us its final advice on covid. If it chooses a vaccine that requires, for example, a 15-minute observation period, we have a very different challenge in co-administration, but nevertheless, wherever possible, we will co-administer. We have made it possible for vaccinated volunteers to administer flu and covid vaccines.
Finally, on funding, I am glad that the right hon. Member agrees that the £5.4 billion announced today is a good thing. I urge him not to speculate on how we will pay for social care and to wait for the announcement; I am sure that we can then discuss it in this place and in the media.
Jeremy Hunt (South West Surrey) (Con)
I have great respect for the excellent job that my right hon. Friend is doing. He will know that Israel shows that even a good vaccination programme does not stop the Delta variant driving up hospitalisations. However, Israel also shows that a booster programme brings down those hospitalisations in as little as two weeks. Given that the big lesson from last year is that acting early can stop the need for lockdowns, as happened in Taiwan, Singapore, Korea and a number of other places, is this not a moment for Ministers to say, “Look, we understand that the scientists want to take their time, but we have a reasonable idea of what they are likely to recommend, so we are going to get on with this booster programme before it is too late”?
Nadhim Zahawi
I am grateful for my right hon. Friend’s excellent question. I would say two things: first, in many ways, the decision taken by our chief medical officers in England, Wales, Scotland and Northern Ireland to increase the dosing interval, including for the vaccine that Israel uses—the Pfizer vaccine—from three to 12 weeks, with it now at an optimal eight weeks, was actually an inspired and clinically incredibly important decision, because it demonstrates, in real-world data, that the durability of the protection is increased over people who have had two jabs with a three-week dosing period. So we are in a slightly more advantageous position, if I can describe it as such.
My right hon. Friend makes an important point on boosters. The booster programme is probably the most important piece of the jigsaw yet to fall into place before we can transition this virus from pandemic to endemic status. I reassure him and the House that the NHS has all the plans in place to deliver the booster programme in what will, in some weeks, probably break our record, which we set in phase 1 of the vaccination programme. The JCVI has given us its interim advice on who needs to boost. It has added, obviously, the immunosuppressed to categories 1 to 4 and it has rightly recommended that we go big on flu. I am equally worried about that. Flu has been non-existent because of the severe social isolation of lockdowns and a big flu season could be detrimental as well. We are ready to go. As soon as cov-boost reports, which is imminent, we will be able to operationalise a massive booster programme.
Dr Lisa Cameron (East Kilbride, Strathaven and Lesmahagow) (SNP)
I thank the Minister for his statement and the update on the vaccination roll-out for pregnant women and the roll-out to young people and those who are most clinically vulnerable. I thank our NHS staff across the four nations, who have dealt with wave after wave of the pandemic and are now at the forefront of the vaccination strategy.
We welcome the additional funding and I seek reassurance from the Minister that, particularly when it comes to young people, there is a holistic approach, so that we deal with not just the physical health aspects, but the mental health aspects. As the chair of the all-party parliamentary health group, I have been inundated with concerns from people across the United Kingdom who cannot access services for young people with eating disorders, for those who self-harm and require crisis intervention, and for those who require the diagnosis of autistic spectrum disorder to receive the support that they need. The Royal College of Psychiatrists has described a “mental health crisis” that could plague the current generation of children for years to come. Will the Minister acknowledge that a holistic approach is needed, alongside the vaccination strategy, to make sure that we support young people’s mental health and mental health across the generations, as well as to make sure that the funding also reaches the mental health needs of the population at large?
Nadhim Zahawi
I am grateful for the hon. Lady’s words of support and for her focus, quite rightly, on mental health. She will know that prior to today’s announcement of £5.4 billion, we also delivered £270 million to primary care for GPs to deal with capacity issues, because they are dealing so well with the covid vaccination programme. However, she makes a very important point that we are very cognisant of and focused on.
Miriam Cates (Penistone and Stocksbridge) (Con)
As my hon. Friend said, the Government have referred the question of the mass vaccination of healthy children to the chief medical officer, asking him to take into account wider benefits such as the avoidance of disruption to education. However, school closures and restrictions are a political choice, not a scientific inevitability, as the wide variation in school days lost by children in countries around the world shows. Does my hon. Friend therefore agree that the CMO should base his recommendation on the benefits and risks to children’s health and wellbeing from the vaccination itself, rather than on any potential political decisions that may be taken in future?
Nadhim Zahawi
Without putting words into the mouth of the chief medical officer for England, Chris Whitty, I can tell my hon. Friend that the work that he is conducting with his fellow chief medical officers looks specifically at the impact on 12 to 15-year-olds. However, the JCVI looked particularly at the area in which its competence lies and made a recommendation that the chief medical officer should look beyond that to mental health and other areas. That is why he is convening a group of experts from local public health, as well as the royal colleges.
Dr Rupa Huq (Ealing Central and Acton) (Lab)
The Minister has some quite fantastic figures about the 16-to-17 cohort, but as a mum of one in west London, may I say that my own boy and all his circle are being diverted to the national booking system? Their generation like doing things at the last minute, so instead can we have more pop-ups and more festivals like the scenes that we saw at Twickenham earlier this year? They do not want to go down the oldies’ routes. Failing that, there are schools, which in my day meant the nit nurse.
Nadhim Zahawi
Yes, absolutely. We are making it as easy as possible for them to simply walk in and get their jab.
Mr William Wragg (Hazel Grove) (Con)
Given the overwhelming evidence, both moral and practical, against covid vaccine passports, will my hon. Friend rediscover the courage of his own convictions, as he once described the proposal as “discriminatory”? If the idea behind the scheme is not his own, will he kindly convey a message to our right hon. Friend the Chancellor of the Duchy of Lancaster to desist from his machinations?
Nadhim Zahawi
This is an incredibly difficult area, but let me try to describe the challenge here. To keep industries such as the nightclub industry open and sustainable, especially in the next few months, we have to look very seriously at how we keep them safe and not have super-spreader events. We have seen other countries having to shut down nightclubs the moment they reopen them. The worst thing for the industry is to open and shut, open and shut, which is why we are looking to introduce a covid certificate by the end of September for domestic use in large gatherings indoors, especially where we have seen mass spreader events.
Munira Wilson (Twickenham) (LD)
The Minister will be aware that there are 3.7 million clinically extremely vulnerable people in this country who had to shield for many months. Many have continued to shield or take far greater precautions than the rest of us since restrictions have eased, and they have had very slow and inconsistent guidance at times. Will he prioritise that group in totality by prioritising booster jabs for the whole group, not just for the half million most at risk? We really need to keep the most vulnerable people safe.
Nadhim Zahawi
I do not disagree with the hon. Lady; I know what she is talking about. She will have seen the interim advice from the JCVI on phase 1, which is for categories 1 to 4, and phase 2, which is for categories 5 to 9—including category 6, the largest category of those people she describes. The JCVI has yet to deliver its final advice post the cov-boost study data. As we have done throughout the deployment, we will follow the JCVI advice.
Dr Caroline Johnson (Sleaford and North Hykeham) (Con)
The JCVI has assessed the known risks and benefits of the covid vaccine for 12 to 15-year-olds and has not recommended it. As the Minister said, the Health Secretary has now referred the matter to the chief medical officers so that they can look at it from a so-called “broader perspective”. Now that children are attending school, half of them have had covid already, they do not need to isolate unless they test positive and they do not need to isolate if they are merely a contact, does the Minister agree that disruption to education will now be much less severe? Furthermore, does he agree that it is not reasonable to use political decisions about schools as leverage to force vaccines on a population of children?
Nadhim Zahawi
I am grateful for my hon. Friend’s very thoughtful question. I can reassure her that there is no political decision making; the process that the chief medical officers are undertaking is unencumbered by any political motivation whatsoever. We will absolutely follow their advice, and the JCVI is in the room as they are deliberating. It is important to recall that the JCVI advice was that vaccination is marginally more beneficial to healthy 12 to 15-year olds than non-vaccination, but not enough to recommend a universal vaccination programme. It is also worth reminding the House that we have been vaccinating 12 to 15-year-olds who are more vulnerable to serious infection and hospitalisation, as the JCVI recommended.
Jeff Smith (Manchester, Withington) (Lab)
On vaccine passports for nightclubs, the Minister said yesterday:
“The best way we can keep those industries open…is to work with the industry”.
Does he recognise that industry representatives do not support the proposal? The Night Time Industries Association has said that
“it will cripple the industry.”
Not only is it impractical and indeed unworkable, but it could potentially lead to an increase in illegal events, raves and large house parties—the kind of super-spreader events that the Minister is worried about. In those cases, there will be fewer safety measures. This is a hammer blow for an industry that has suffered more than almost any other over the past year and a half. Will he take its concerns into consideration and think very carefully before bringing such a proposal forward?
Nadhim Zahawi
The hon. Member raises important points from the industry and we will always make sure that we look at them. One piece of feedback from our earlier consultation was that to be able to check IDs, for example, we would want to make this process equally straightforward for the industry.
Sir Mike Penning (Hemel Hempstead) (Con)
I completely support—the whole House will concur—the fantastic work that the NHS has done through the vaccine programme. It is great news that they are coming forward and are ready, but the army of volunteers I saw and worked with in my constituency are exhausted. They need to know up front how often and when they will be needed, because the programme cannot happen without not just vaccinations from the NHS, but the army of people who come forward and put their own lives at risk so others can be safe.
Nadhim Zahawi
My right hon. Friend raises an incredibly important point that we look at every single day. In my ops meetings, we have a section dedicated to the workforce and specifically to the volunteers, so that we can make sure that they are put on notice of where and when we think we will need them. The only caveat that I would add is that we have built a very large infrastructure, but it has to flex depending on the advice from the JCVI, the MHRA and, of course, our chief medical officers.
Mr Alistair Carmichael (Orkney and Shetland) (LD)
It will not be lost on many people that the various lines of defence that the Minister listed in his statement did not actually include his plans for vaccine passports, presumably because they do not offer us any defence at all. Taking a leaf from the book of the hon. Member for Hazel Grove (Mr Wragg), may I remind the Minister of what he said on Twitter on 12 January? He wrote:
“We have no plans to introduce vaccine passports…No one has been given or will be required to have a vaccine passport.”
When no less a person than Claire Fox said,
“Good to hear. Again. Can we hold you to this?”,
the Minister replied:
“Yes you can Claire.”
For Claire and the many others like her who want to hold the Minister to his words, may I ask when we will get the vote that he promised us?
Nadhim Zahawi
I am grateful for the right hon. Gentleman’s question. It is an important question that I want to address head-on, because it is about statements on Twitter; I understand that I am “trending” on Twitter.
I was asked about this by Tom Swarbrick, who replayed to me my February interview. I said to him that the difference between then and now was first that the Delta variant is so much more infections than the previous variants—it takes only a very few particles for someone to be infected—and secondly that we have learnt from the experience of other countries which attempted to reopen sectors such as the nightclub sector and then had to close them rapidly because of super-spreader events. We do know that 60% of people who have had two jabs will not become infected with the Delta variant and therefore cannot infect someone else, although 40% will and can. This is a relative risk that we want to avoid: what we do not want to do is open the industry and then have to shut it down again because of those super-spreader events.
I hope that I have explained myself to the House. It is important that when politicians have new evidence—new data—they are able to change their minds.
Steve Brine (Winchester) (Con)
All UK adults have now been offered a first dose, and I think it is worth reflecting on what a remarkable achievement that is on the part of the country, the volunteers and indeed the Minister, who deserves a great deal of credit. We have long since protected the vulnerable, and surely very soon we will offer them that booster jab.
Until this point I thought I had understood the strategy completely, but now I am not so sure. What is it? Is it about case numbers, which we still broadcast every day? We never did that when I was in the Minister’s Department and influenza was having a bad year.
My question goes to the heart of the stuff about covid status certification, and about vaccinating healthy children. In short, what is the strategy now? What do the Government mean when they say we must learn to live with covid? Could the Minister give us his view?
Nadhim Zahawi
I am grateful for my hon. Friend’s important and thoughtful question, and for his words of encouragement as well.
Let us look at what the vaccines have achieved. We have achieved a situation in which we have weakened—severely weakened—the link between cases going up rapidly, serious infection, hospitalisation and death. We are in a very different place today. This new equilibrium is where we want to be able to head to in steady state. The challenge that will come over the next few weeks and months is that there will be upward pressure on that equilibrium. We may break it in the wrong way because schools are reopening, there will be a higher number of infections, and those infections could seep through to the older age groups who are much more vulnerable. The booster campaign would help to push it the right way, with the infection rates being forced up but not leaking into the most vulnerable. That is why the JCVI stressed that we should boost the most vulnerable first.
I hope that this next challenge will enable us to demonstrate to the world that we are one of the first major economies in the world to bring about the transition of this virus from pandemic to endemic and then live with it over the years to come, through an annual vaccination or inoculation programme.
Dame Meg Hillier (Hackney South and Shoreditch) (Lab/Co-op)
It is interesting to note that the Minister has a short-term job in some respects, as the vaccines Minister. He should perhaps recognise that some of us are in favour of covid passports because they should also be a short-term measure, and it will probably be a sign of his success if they are.
My main point, however, is that the Minister dangled in front of us—although I know that this is not in the written statement that was circulated—the extra money going into the NHS. I have mentioned the short-term nature of the Minister’s job in some respects, but it is long-term funding that is needed. We know that money injected at short notice in large amounts is not always spent very well, even by our beloved health service, and I have direct experience of recruitment processes whereby posts have become pretty much redundant by the time people have been recruited to them. What is the Minister’s Department doing—and what is he doing personally if he has some responsibility in this regard—to ensure that the money will be spent well, and that there is a long-term financial plan for recovery?
Nadhim Zahawi
I have grateful for the hon. Lady’s words, including those about the issue of vaccine certification, on which I agree with her. No one in this Government, and certainly not this Prime Minister—as I said at the weekend, it goes against his DNA—wants to curtail people’s freedoms, so we will not do this lightly at the end of September. As for her question about the funding, let me try and give her some more details.
The £5.4 billion cash injection over the next six months in response to covid-19 includes £1 billion to help tackle the backlog, delivering routine surgery and treatments for patients. As I said in my statement, the total Government support for the health service is £34 billion in this year alone. The funding will go towards helping the NHS to manage the immediate pressure of the pandemic. As I have said, it includes an extra £1 billion to help tackle the backlog, along with £2.8 billion to cover related costs such as those of the enhanced infection control measures that are so important to keep staff and patients safe from the virus, and £478 million to continue the hospital discharge programme, freeing up beds.
Dr Andrew Murrison (South West Wiltshire) (Con)
Six years ago we lost 28,000 people to seasonal flu. Can the Minister assure me that we will not prioritise the jabbing of 12 to 15-year-olds over the seasonal flu programme, given that the number of children whom we would lose to covid would be vanishingly small in any event? Can he also assure me that in his planning he has considered not only the 15-minute wait that the Pfizer jab requires, but the extra time and effort that are required to get truly informed consent from children whose motivation cannot be clinical, must be altruistic, and may be subject to peer pressure?
Nadhim Zahawi
Let me try to unpack my hon. Friend’s question. First, no decision has been made on vaccinating 12 to 15-year-olds who are healthy. We are vaccinating those who are vulnerable. We will not pre-empt the important work that the chief medical officers are doing and on which they are experts. Operationally, we have the infrastructure to be able to deal with both programmes.
The flu and covid booster campaigns are the largest endeavours. As I said earlier, in some weeks we will probably break the record that we set in the original covid vaccination programme. The flu vaccine is traditionally delivered through the brilliant work of GPs and, of course, community pharmacies, and they are doing that again. They have raised their ambition and ordered more than they did last year—which was a record-breaking year—and we have procured centrally as well. I can reassure my hon. Friend that that is our priority. I worry very much about a bad flu season this year, which is why we have been so much more ambitious in that regard, as well as on the covid booster campaign.
Wendy Chamberlain (North East Fife) (LD)
In his statement, the Minister emphasised that universities should get double jags, but before the recess I highlighted the case of students who had had a jag in Scotland and a jag in England, and had been unable to travel abroad because their covid certification was not clear. At the time, someone from NHS Digital said that they were working on doing the same in England with the NHS covid pass. Given that people who have jags in different parts of the four nations may be discriminated against by vaccine passports, can the Minister provide an update on how that is progressing?
Nadhim Zahawi
I will go back and check, but I am almost certain that the NHS England system is now able to take in data from Scotland, Wales and Northern Ireland in terms of jabs—or jags.
Jane Stevenson (Wolverhampton North East) (Con)
I thank the Minister for his statement, and also for recognising the young people who were at low risk but have taken up the offer of a jab to protect more vulnerable people in their families, workplaces and communities.
The figures that the Minister presented on pregnant women needing hospital treatment for covid were very stark. Can he reassure me that pregnant ladies are obtaining advice at the earlier possible opportunity from their GPs or midwives, and are themselves being reassured that the jab is safe for them and for their unborn children? Those figures would certainly hit home with them.
Nadhim Zahawi
I can give my hon. Friend that reassurance. We have a pretty substantial outreach programme, including webinars with midwives so that they are given all the available tools to ensure that pregnant women are given the protection that they so vitally require.
Tim Farron (Westmorland and Lonsdale) (LD)
The effective cut-off for care home staff to get their first jab in order to comply with the Government’s deadline is just 10 days away, and those who are not double-jabbed in time will not be able to work in care homes. However, there has yet to be any unequivocal guidance on who will be exempt from this, and care home managers in my constituency are desperately concerned, especially in the light of the most unprecedented care home staffing crisis in a generation. They are desperate for that guidance. Will the Minister provide it today?
Nadhim Zahawi
The hon. Gentleman is absolutely right: 11 November is the date by which care homes and care home providers will have to comply with the legislation on the vaccination programme. I would be happy to share with him the guidance and the communication that we have sent out to the sector, and I will write to him after this statement.
David Mundell (Dumfriesshire, Clydesdale and Tweeddale) (Con)
I particularly welcome what the Minister had to say about pregnant women. My own daughter is expecting a baby in January, and she found it very difficult to get such definitive advice earlier in the summer, although she has now had her jab. I want to ask the Minister specifically about another issue. How can UK citizens who have had their vaccinations abroad ensure that those vaccinations are held up as valid here in the United Kingdom? For example, I have a constituent who had his AstraZeneca vaccinations in Saudi Arabia and is struggling to have them recognised here.
Nadhim Zahawi
My right hon. Friend is absolutely right; we are working flat out. We have the pilot scheme in which we recognise vaccinations from America and Europe, and we are looking to expand that to other countries so that people who have had a vaccines from a list of approved vaccines in those countries can benefit from the same freedoms that people who have been double-vaccinated in the UK have.
Jim Shannon (Strangford) (DUP)
I thank the Minister for his statement. Can he reaffirm that no child will be vaccinated without explicit parental consent, and that, should consent not be given, that will not affect the child’s education in terms of school outings, sporting events or residentials? Does he believe that this protection needs to be further enshrined in law?
Nadhim Zahawi
I repeat to the House that no decision has been made on vaccinating 12 to 15-year-olds. We have to allow the chief medical officers to do the work that they need to do, with the JCVI in the room, and to come back to us. I will return to the House and share with Members the decision that is made. In terms of school-age vaccination programmes in general, parental consent is always required, and the NHS is well-versed in effectively receiving that consent. On the rare occasions when there is a difference of opinion between the child and the parents, the child’s competence and level of understanding of the vaccine come into play. NHS clinical advice is very much that that is a rarity, and parental consent is required for school-age vaccination programmes.
Nick Fletcher (Don Valley) (Con)
The vaccination roll-out has been excellent; no one can dispute that. However, I have two issues, one of which has just been covered, on the proposals to vaccinate young people. First, if the benefits of doing that are so small and we are vaccinating children to protect the wider public, should we not be asking the many adults who have not yet been vaccinated to get vaccinated now and stop placing further pressure on our young people who have suffered enough to protect the elderly throughout the pandemic? Secondly, if we still decide to offer vaccinations to 12 to 15-year-olds, does my hon. Friend agree that this should ultimately be the parents’ decision? I fear that removing the responsibility that parents have for their children in this area, and in many others, could have unknown consequences for family relationships for many years to come.
Nadhim Zahawi
I reiterate that the work that the chief medical officers are carrying out is looking at the impact of this—whether it be educational, psychological or relating to the public health impact—on 12 to 15-year-olds. As I say, they will then come back with their advice, having had the JCVI in the room for those deliberations. Parental consent is required in any school-age vaccination programme, but I do not want to pre-empt this decision. No decision has yet been made, but parental consent would be required. On the very rare occasions when there is a difference of opinion, Gillick competence applies.
James Gray (North Wiltshire) (Con)
May I take this opportunity—the first one after lockdown, I think—to thank the Minister, his officials and the whole of the national health service for the fantastic job that they have done and for their brilliant roll-out of the vaccine? Will he join me in congratulating the Order of St John, which has done a huge job in carrying out the vaccinations and in training and co-ordinating volunteers? It has done a brilliant job, and it is worthy of our thanks.
Nadhim Zahawi
I will absolutely join my hon. Friend in congratulating St John’s volunteers, who have done a phenomenal job. They really rose to the challenge when we contacted them and said that we needed them. They delivered in spades. I thank my hon. Friend for all his words: this has been a massive team effort involving the health service, the public sector and of course the private sector as well.
Dr Ben Spencer (Runnymede and Weybridge) (Con)
I would like to thank my hon. Friend for the incredible vaccine roll-out; many lives have been saved by it. My question is about domestic vaccine passports, and I have to apologise because I get a bit confused by the nomenclature of what is being proposed. On the one hand, we have what I understand to be vaccine-only passports, which say simply that someone has been vaccinated and that that is all that counts. Then we have covid status certification, which can also include negative testing and proof of recent infection. Crucially, this is not just about whether someone has been vaccinated, because as I understand it, a lateral flow test negative result is the best evidence that someone is no longer infectious. Is my understanding correct that the proposal for the end of September is for vaccine-only domestic vaccine passports? If that is the case, why has that moved from covid status certification?
Madam Deputy Speaker (Dame Rosie Winterton)
Order. Just before the Minister answers, I must point out that we need to finish this statement fairly shortly. Colleagues should keep their questions very short, and the answers should be correspondingly short.
Nadhim Zahawi
I am grateful to you, Madam Deputy Speaker, and to my hon. Friend for his question. I guess the reason for the shift by the end of September, when all 18-year-olds will have had the opportunity to get two jabs, is that testing provides a limited protective assurance and allows for the potential for self-testing fraud. The effectiveness of testing-based certification can also be undermined by a single incursion into a setting. Transmission, serious illness and hospitalisation are reduced using vaccination-based certification, even with incursions, so that is the thinking behind this. I reiterate that nobody does this lightly. We do not curtail people’s freedoms lightly; this is purely so that we can keep industries and sectors open and not have to close them down again if there is a super-spreader event.
Mr Peter Bone (Wellingborough) (Con)
I thank the excellent Minister for coming to the Dispatch Box. When are we going to get the debate and the vote on vaccine passports?
Holly Mumby-Croft (Scunthorpe) (Con)
Can my hon. Friend reassure residents in Scunthorpe that the very welcome booster programme will make full use of pharmacies and our fantastic vaccination hubs and, if possible, those routine contacts such as winter flu jab appointments and asthma checks, to ensure that we do not lose any GP appointment time over these much-welcomed boosters?
Nadhim Zahawi
My hon. Friend is quite right to say that GPs need to do more than just the vaccination programme, the booster programme and the flu vaccination programme. We also have to recognise that they do an incredible job in protecting the most vulnerable from flu, and that they were the backbone of the covid vaccination programme. We are continuing to work with primary care networks, but we have enhanced the pharmacy offer as well. I will be able to set out more detail on that when we begin the booster programme.
Duncan Baker (North Norfolk) (Con)
I am sorry to press the Minister on a hot topic, but although I understand the need for limited and specific use of vaccine passports—perhaps in nightclub settings, which are particularly risky, as he has said—the admission yesterday that the proposal had been expanded to include larger venues and gatherings is really beginning to concern my constituents, especially when we have vaccinated around of 80% of the population. Will this be a high water mark for their use, and when will the criterion potentially end?
Nadhim Zahawi
My hon. Friend has heard me say today that no one embarks on this lightly, and it is not in the Prime Minister’s DNA to curtail people’s freedoms. It is purely so that we can have sustainable continuation of an open economy that we would introduce such programmes. I do not know—if anyone claims otherwise, they are foolhardy or foolish—when we can definitely say that the virus has transitioned from pandemic to endemic status.
Chris Green (Bolton West) (Con)
Medical autonomy on vaccinations has been removed from workers in care home settings, so when will medical autonomy be removed from nurses, doctors and consultants in the NHS?
Nadhim Zahawi
In the original consultation on social care conditions of deployment, which we eventually introduced and have discussed today, part of the feedback was that we should consult on the wider health service, including frontline healthcare workers. By the way, I commend both social care and healthcare workers because the majority of them have come forward to be vaccinated. Indeed, more than 94% of frontline healthcare workers have had both doses. We will bring forward a consultation on this, because there is a duty of care for those looking after vulnerable people in hospitals or care homes to be protected against covid.
Jack Brereton (Stoke-on-Trent South) (Con)
Delivering covid booster jabs alongside flu vaccinations presents additional operational challenges. Will my hon. Friend do everything possible to co-ordinate these jabs, to ensure that we have very high uptake and to ensure the jabs arrive in Stoke-on-Trent in good time?
Dr Julian Lewis (New Forest East) (Con)
Is there any risk to older age groups who, because they are more vulnerable, had both jabs earlier, that the effectiveness of those jabs might wear off sooner and that there might be a gap of vulnerability before they can get their booster shots?
Nadhim Zahawi
My right hon. Friend is right to highlight that there is a group of older patients who received both doses with a three-week dosing interval, not a 12-week dosing interval. They will be our priority when it comes to boosters. The data from Cov-Boost is imminent, as I said earlier. The system is ready and primed to go as soon as we have that data, so that we boost the most vulnerable, including the group to which he refers, as quickly as possible to offer that additional protection.
Rob Butler (Aylesbury) (Con)
During the summer I visited the “Grab a Jab” van in Aylesbury, which proved especially popular with younger people. Will my hon. Friend join me in congratulating everybody involved in rolling out that vaccination programme and in encouraging all 16 and 17-year-olds in the Aylesbury constituency to get their jab so that they can live a full life, whether studying, working or just having a good time?
Nadhim Zahawi
I certainly urge all 16 and 17-year-olds to come forward to get their jab and the protection and freedoms that go with it. I thank the “Grab a Jab” team in Aylesbury for all the work they have done.
Mike Wood (Dudley South) (Con)
The strongest incentive for getting the vaccine is obviously to protect yourself and your loved ones. Although the risk of covid to secondary school-age children may be low, the risk to those they live with could be much higher. Will the chief medical officers consider offering covid vaccines to 12 to 15-year-olds who live with immunosuppressed or other extremely clinically vulnerable people in their household?
Nadhim Zahawi
My understanding is that, for 12 to 15-year-olds who are healthy, the chief medical officer is looking at the impact on them specifically, whether it be their mental health or the other impacts of disruption to education. He is consulting widely with local directors of public health and the Royal Colleges.
Covid-19 Update
Nadhim Zahawi Excerpts(3 years, 2 months ago)
Written StatementsRead Full debate Read Hansard Text Read Debate Ministerial Extracts
The Minister for Covid Vaccine Deployment (Nadhim Zahawi)
Through the covid-19 vaccines programme, we have administered over 90 million vaccine doses in the UK, with recent PHE data suggesting that this has prevented over 24 million infections, 105,900 deaths and 82,100 hospitalisations in England alone. The vaccines are the most effective way of protecting the most vulnerable and minimising hospitalisations and deaths.
The independent Joint Committee on Vaccination and Immunisation (JCVI) continues to consider emerging data. When Parliament was in recess the Committee provided advice in favour of:
offering initial vaccination to all remaining 16 and 17-year-olds;
offering a third dose in the primary vaccine schedule to all those aged 12 and over defined as severely immunosuppressed;
and expanding the groups of 12 to 15-year-olds defined as at risk.
Her Majesty’s Government (HMG) reviewed and accepted the advice. All four parts of the UK have accepted the JCVI’s advice and will align their deployment in each nation.
I am tabling this statement for the benefit of hon. and right hon. Members to bring to their attention the contingent liabilities relating to the expansion of the covid-19 vaccine programme taken during the summer recess.
Initial vaccination to all remaining 16 and 17-year-olds:
JCVI published further advice on the vaccination of children and young people on 4 August.
JCVI advised that all remaining 16 to 17-year-olds should be offered a first dose of Pfizer-BNT162b2 vaccine. This is in addition to the existing offer of two doses of vaccine to 16 to 17-year-olds who are in “at-risk” groups or in roles which present a high risk of transmission to vulnerable people.
Third dose in the primary vaccine schedule to all those aged 12 and over defined as severely immunosuppressed:
JCVI published its advice on vaccination for individuals with severe immunosuppression on 1 September.
JCVI advised that a third primary vaccine dose be offered to individuals aged 12 and above with severe immunosuppression in proximity of their first or second covid-19 vaccine doses in the primary schedule with a preference for mRNA vaccines for those aged 18 and over. Whether patients are eligible will be determine by their specialist clinician. For young people aged 12 to 17 years, the Pfizer-BNT162b2 remains the preferred choice.
A third primary dose is recommended for individuals with severe immunosuppression in order to bring these individuals up to nearer the same level of immunity that healthy individuals achieve through two primary doses, and this group will become eligible for a booster dose as part of a routine booster programme from around six months after their third primary dose, pending further advice.
Expanding the groups of 12 to 15-year-olds defined as at risk:
JCVI published further advice on expanding the vaccine offer to certain children and young people on 3 September.
JCVI advised that the offer of a course of vaccination should be expanded to include children aged 12 to 15 years with the following conditions:
Haematological malignancy
Sickle cell disease
Type 1 diabetes
Congenital heart disease,
Other health conditions as described in Public Health England’s Green Book
This is in addition to the conditions specified in the existing advice on at risk 12 to 15-year-olds published on 19 July. JCVI advised that this group is offered a two-dose course of vaccination with Pfizer-BNT162b2 vaccine as the preferred option.
With deployment of additional doses of vaccines to severely immunosuppressed individuals and new groups of young people over the parliamentary summer recess, I am now updating the House on the liabilities that HMG have taken on in relation to further vaccine supply via this statement and attached departmental minutes containing descriptions of the liability undertaken. The agreement to provide indemnity with deployment of further doses to the population increases the statutory contingent liability of the covid-19 vaccination programme.
Deployment of effective vaccines to eligible groups has been and remains a key part of the Government’s strategy to manage covid-19. Willingness to accept the need for appropriate indemnities to be given to vaccine suppliers has helped to secure access to vaccines with the expected benefits to public health and the economy alike much sooner than may have been the case otherwise.
Given the exceptional circumstances we are in, and the terms on which developers have been willing to supply a covid-19 vaccine, we along with other nations have taken a broad approach to indemnification proportionate to the situation we are in.
Even though the covid-19 vaccines have been developed at pace, at no point and at no stage of development has safety been bypassed. The MHRA approval for use of the currently deployed vaccines clearly demonstrates that this vaccine has satisfied, in full, all the necessary requirements for safety, effectiveness, and quality. We are providing indemnities in the very unexpected event of any adverse reactions that could not have been foreseen through the robust checks and procedures that have been put in place.
I will update the House in a similar manner as and when other covid-19 vaccines or additional doses of vaccines already in use in the UK are deployed.
HM Treasury has approved the proposal.
[HCWS257]
Covid-19 Update
Nadhim Zahawi Excerpts(3 years, 3 months ago)
Commons ChamberRead Full debate Read Hansard Text Watch Debate Read Debate Ministerial Extracts
Mr Speaker
Before I call the Minister to make his statement, I have to say that I am far from happy that yesterday the House heard from a Health Minister giving an update with no mention at all of the NHS pay deal, which is a point of great political interest. I find it hard to believe that any negotiations were still going on beyond that time. I urge the Government again to ensure that the House is the first, not the last, to know. It is not my fault that the Secretary of State got pinged, and if he wants to make announcements from his garden, he can do so, but somebody could have been here and Ministers could have shared that information with us. Glorying in the sunshine should not detract from this House hearing an announcement when it is made. It matters to all of us—we all have hospitals in our constituencies, and we all have constituents who work for the NHS, so the clear message once again is that this House should be told. Now then, let us come to a man who has come to the House to make a statement. I call Minister Nadhim Zahawi to make a statement.
The Minister for Covid Vaccine Deployment (Nadhim Zahawi)
Thank you, Mr Speaker, and may I offer the apologies of the Secretary of State and the Department of Health and Social Care on the inability of the Department to make a statement on the acceptance by the independent pay review body that NHS staff should get 3%? I hope you will accept my apology on behalf of the Secretary of State, as he is self-isolating.
Mr Speaker
I really do appreciate that, and the Minister is so courteous, but it makes it worse that a Minister was actually at the Dispatch Box when all that was going on outside, and for them to turn to the House and say, “I can’t tell you”—not “I don’t know”, but “I can’t tell you”—is even more worrying.
Nadhim Zahawi
You make a very powerful point, Mr Speaker.
Before I turn to my remarks today, I want to say something to you, Mr Speaker. I want to take a moment ahead of the House rising for the summer recess to thank you, sir, and everyone who works here in Parliament, your whole team, for everything you have done to keep us all safe over the past few months. The fact that we have kept our democracy running, and running safely, at this time of crisis is an incredible achievement, and we are all extremely grateful to you and your team.
With permission, Mr Speaker, I would like to make a statement on the covid-19 pandemic. This week, we have taken a decisive step forward, taking step 4 on our road map and carefully easing more of the restrictions that have governed our daily lives. Although we are moving forward, we must remember that we are doing so with caution, because the pandemic is not yet over. The average number of daily cases in England is around 41,000 and hospitalisations and deaths are rising too, although at a much lower level than when we had that number of cases during previous waves. So even as we take step 4, we urge everyone to think about what they can do to make a real difference.
Today, we are launching a new campaign to encourage everyone to keep taking the little steps that have got us this far, such as wearing face coverings in crowded public areas, making sure that rooms are well ventilated and getting regular rapid tests. We are also supporting businesses and organisations, helping them to manage the risk of transmission within their venues, including through the use of the NHS covid pass for domestic use. I know that this has been of great interest to Members and want to use this opportunity to reiterate the policy and offer the House the chance to have its say.
This week, after a successful trial, we have rolled out the NHS covid pass, which allows people safely and securely to demonstrate their covid status, whether that is proof of vaccination status, test results or natural immunity. Anyone can access a pass via the NHS app, the NHS website or by calling 119 and asking for a letter to demonstrate vaccine status. People will also be able to demonstrate proof of a negative test result.
Although we do not encourage its use in essential settings such as supermarkets, other businesses and organisations in England can adopt the pass as a means of entry, where it is suitable for their venue or premises and when they can see its potential to keep their clients or customers safe. For proprietors of venues and events where large numbers are likely to gather and mix with people from outside their household for prolonged periods, deploying the pass is the right thing to do. The pass has an important role to play in slowing the spread of the virus, so we reserve the right to mandate its use in future.
Next, I wish to update the House on vaccination as a condition of entry. We all know the benefits that both doses of a vaccine can bring. Data from Public Health England estimates that two doses of a covid vaccine offers protection of around 96% against hospitalisation. Today, we have new data from Public Health England that estimates that the vaccination programme in England alone has prevented 52,600 hospitalisations. That is up 6,300 from two weeks ago and is a fitting example of the protective wall that our vaccination programme has given us—a wall that is getting stronger every day. That protection has allowed us carefully to ease restrictions over the past few months, but we must do so in a way that is mindful of the benefits that both doses of the vaccine can bring. This strategy—this philosophy—will underpin our approach over the critical next few months.
This week, as part of our step 4 measures, we allowed fully vaccinated adults and all children to return from amber-list countries without quarantine—with the exception of those returning from France, because of the persistent presence of cases of the beta variant. From 16 August, children, under-18s and people who are fully vaccinated will no longer need to self-isolate as contacts, given their reduced risk of catching and passing on the disease. As I said when I updated the House on Monday, at the end of September we plan to make full vaccination a condition of entry to those high-risk settings where large crowds gather and interact. By that point everyone aged 18 and over will have had the chance to be fully vaccinated, so everyone will have had the opportunity to gain the maximum possible protection.
As a condition of entry to such venues, people will have to show that they are fully vaccinated, and proof of a negative test will no longer be sufficient. This is not a step that we take lightly, but throughout the pandemic, like Governments across the world—in Singapore, Australia, Germany and France—we have had to adapt our approach to meet the threats of this deadly virus. This step is no different. We will always keep all our measures under review, with the goal of returning to the freedoms we love and cherish.
We should all be proud of the enthusiasm for and uptake of our vaccination programme. Now, 88% of all adults have had a first dose and 69% have had both. That uptake means that the latest Office for National Statistics data shows that nine in 10 adults now have covid-19 antibodies. However, there are still many people who are unprotected, including 34% of people aged 18 to 29 who have not had either dose. Ahead of the summer recess, I would like once again to urge everyone to come forward and get both doses, to protect themselves and to protect their loved ones and their community.
Our battle against this virus is not the kind of battle where we can simply declare victory and move on with our lives. Instead, we must learn to live with the virus, doing whatever we can to slow its spread while we maintain the vital defences that will keep us safe. That is exactly what this Government will do and I commend the statement to the House.
Jonathan Ashworth (Leicester South) (Lab/Co-op) [V]
I thank the Minister for advance sight of his statement. Let us be frank: it was a shambles yesterday. It was an insult to the House and a let-down for health and care staff.
Ministers have been dragged kicking and screaming to this 3% settlement. Can the Minister accept—and does he accept—that it is not an NHS-wide settlement, as it does not cover the health and care workforce who do not fall under the pay review body? For example, it does not cover our junior doctors who have had an intense year caring for sick patients on ventilators, who have been redeployed to other sites across the NHS and who have seen their training disrupted. Will the junior doctors get a pay rise, especially given that the pay review body, in paragraph 10.6 of its report, urges the Government to recognise the role of doctors who are out of scope? Will all health staff who work in public health receive the settlement? Care workers are obviously not covered by the pay review, and we know how valuable they are, so will care workers finally get the real living wage that they deserve?
How will the pay settlement be funded? NHS trusts do not even know what their budget will be beyond September. The Health Secretary has said that the pay settlement costs £2.2 billion, so where is that £2.2 billion coming from? Is he expecting trusts and general practice to find it from their existing budgets? At a time when the NHS is in a summer crisis, with covid admissions increasing and more patients on ventilators in hospitals, with operations being cancelled again and waiting times growing because of the pressures the NHS is under, rather than getting a funded settlement for the NHS we have seen this week briefing and counter-briefing from the Health Secretary, the Chancellor and Downing Street about what may or may not be coming for health and social care.
The NHS needs more investment now to cope with the pressures that it is under. Will the Minister confirm that the Government will break their manifesto pledge to increase national insurance, or is the Business Secretary correct in what he said this morning? He said:
“I don’t see how we could increase national insurance”.
The Prime Minister promised, on the steps of Downing Street two years ago this Saturday, that he would have a social care plan, but this is not a plan for health and social care; it is a Government in disarray.
That brings me on to the so-called pingdemic, with the problems of isolation. The problems of isolation that we are seeing are a symptom of what happens when Ministers allow infections to get out of control. The Government are apparently U-turning today and agreeing a list of workers who could be exempt from isolation, based on a negative PCR test. With infections running at more than 50,000 a day, and possibly on the way up to 100,000 a day, can the Minister absolutely guarantee that PCR testing capacity will be available to cope with the inevitable increased demand this summer?
If the Minister wants to avoid shutting society down, he needs to bring infections down, so why have the Government ruled out extending statutory sick pay to the lowest-paid, and what is he doing to drive up the vaccination rate among younger adults? He knows that allowing infections to rise among that cohort sets his vaccination programme back, given that somebody has to wait 28 days post-infection for vaccination.
Today the Minister has repeated his support for vaccine passports. Can he explain why he thinks it is safe to go out clubbing into the early hours this Friday, but in September it is only safe to go out clubbing if everybody is double-jabbed? Can he confirm when the relevant statutory instrument will be laid, and when the vote will be on introducing those passports?
The Minister has a proposal for nightclubs in September, but does he have a proposal for schools in September? A million children have been off school recently, so, as we asked him on Monday, will he use this summer to install air filtration units in schools in time for September, and is he considering bringing mask-wearing back in schools?
Finally, Mr Speaker, may I, like the Minister and others across the House, thank you, and all the staff especially, for the extraordinary work that you have put in, in these last 12 months, to ensure the smooth running of Parliament in these most unprecedented of circumstances? I hope you are all able to have a suitable rest over the summer recess.
Nadhim Zahawi
The right hon. Gentleman asks who is included in the 3% pay rise recommended by the independent NHS Pay Review Body. They are the 1 million NHS staff, including nurses, paramedics, consultants and, of course, salaried GPs. The junior doctors he mentions have a separate, multi-year pay rise over three years, amounting to 8%.
The right hon. Gentleman asks about the capacity for testing. I looked at that before coming to the House, and the capacity currently for PCR tests is not 600,000 but 640,000 a day, according to the latest data that I looked at. He asks about schools. There will be two supervised tests for schools. He knows that in Monday’s statement we announced our acceptance of the JCVI guidelines on vaccinating vulnerable children, vaccinating children who live with vulnerable adults, and vaccinating those who are 17 but within three months of their 18th birthday. The JCVI will keep under review the vaccination of healthy children as more data becomes available from countries such as the United States of America and Israel.
The right hon. Gentleman asked a question around the covid vaccination pass and nightclubs, other crowded unstructured indoor settings such as music venues, large unstructured outdoor events such as business events and festivals, and very large structured events, such as business events, music and spectator sport events. They are the ones that we are most concerned about. We have seen other countries, whether it is Holland or Italy, opening nightclubs and having to reverse that decision rapidly. What we are attempting to do, and the reason we have the covid vaccination pass in place, is to work with industry while we give people over the age of 18 the chance to become double-vaccinated. It would be hugely unfair to bring in that policy immediately. Giving people until the end of September is the right thing to do, while at the same time allowing businesses to open safely, using the app now—because the app went live and the industry is very much engaging with it.
There are no easy decisions on anything to do with this virus. That is the one thing we have learned. The most effective tool we have against the virus is, of course, the vaccine programme, followed by the tool of self-isolation. If we want to get back to normal and get our lives back, we need to transition this virus from pandemic to endemic—from pandemic to manageable menace—as quickly and as safely as possible. If we release all restrictions now, including self-isolation, which I am sure a number of colleagues will ask about today, we risk the number of infections, which the shadow Secretary of State worries about as I do, rising rapidly. That could risk the transition of this virus.
We are working flat out with industry. I commend companies such as Lidl, which knows it is under pressure but will work through it with us. We will allow critical, frontline and key workers and health and social care workers to get back to work if they take a negative test, as I announced on Monday. By 16 August, everyone who is double-vaccinated will be able to do that.
Jeremy Hunt (South West Surrey) (Con)
May I start by wishing you and your family a ping-free summer, Mr Speaker? Thank you for upholding the values of this House over the past few months.
The Minister of State will have heard of YouGov, which said this week that a tenth of the people who had the NHS covid app have deleted it, and that a further fifth are considering doing so. Given that he made his living from listening to public opinion, does he not think it is time for the Government to listen to public opinion and immediately scrap the 10-day isolation requirement for double-jabbed people who are pinged, in favour of having to isolate until they take a negative PCR test? Otherwise we risk losing social consent for this very important weapon against the virus.
With your permission, Mr Speaker, I would briefly like to ask you about the issue we were not able to ask Ministers about in the House yesterday, which is the decision on NHS pay. I support the decision to accept the pay review body’s recommendations. It is the right thing to do, but it costs £1.5 billion. Can the Minister confirm it will not be paid for by cuts to other parts of the NHS budget? If it is going to be funded through a new national insurance rise for health and social care, as The Times says today, will he confirm that the funding for social care will be ring-fenced, so that we do not have a situation in which social care, once again, loses out because of pressures in the NHS?
Mr Speaker
The right hon. Gentleman said “you,” but I was not responsible for the decision yesterday.
Nadhim Zahawi
I will take those questions in reverse order. I thank the Chairman of the Select Committee, my right hon. Friend the Member for South West Surrey (Jeremy Hunt), for his always diligent and thoughtful questions. As he will know, we gave the NHS in England an historic settlement in 2018 that will see its budget rise by £33.9 billion by 2023-24. We have provided over £27 billion to support the NHS in England since the start of the pandemic, including £9.7 billion so far for 2021-22. We will continue to make sure the NHS has everything it needs to continue supporting its staff and providing excellent care to the public, throughout the pandemic and beyond.
My right hon. Friend specifically asked about social care, and I know the Secretary of State and the Prime Minister are committed to making sure we deliver on our social care promise by the end of this year.
Public compliance is incredibly important, and I thank each and every person who has come forward and got themselves protected. Over the past few days, we have seen an almost doubling of the number of people going on to the NHS website to book appointments. There has almost been a doubling of appointments, too, which is incredible, considering where we are at the moment—we are almost touching 90% of all adults. These are the hard yards, and people are still coming forward. There are no easy decisions on this, as I said in answer to the shadow Health Secretary. We know that our most effective tool is the vaccination, but the second most effective is self-isolation. We are attempting to transition this virus from pandemic to endemic status. If we allow all these things to happen too rapidly and people then decide not to self-isolate, we run the risk of infection rates running away with us and challenging the strategy of our being the first major economy to transition. So we are working with business, and we are working flat out with the frontline critical infrastructure and key workers to get that guidance out. I am sure that colleagues in this House will be the first to receive it—I will make sure of that, even during recess.
Dr Philippa Whitford (Central Ayrshire) (SNP) [V]
I wish you, colleagues and all the House staff a safe and happy summer recess, Mr Speaker. Clearly, vaccination is critical to fighting this pandemic. We all need to encourage uptake among younger adults, but is the Minister in a position to guarantee sufficient supplies of Pfizer or Moderna vaccines to vaccinate them before the end of September? Whether this is done legally, as in the case of care homes staff, or through excluding people from social activities, does he recognise that making vaccination mandatory can increase distrust among those who are hesitant and drive them to become outright vaccine refusers? Despite the talk about caution, covid cases in England were already surging when the Government ploughed ahead with lifting all legal restrictions on Monday. Although vaccination has reduced the hospitalisation rate to between 2% and 3%, the Secretary of State suggested that covid cases could soar to 100,000 a day, which would result in 2,000 to 3,000 admissions, which is similar to what happened in the first wave. Does the Minister really not recognise that that would put health services under enormous pressure and cause the patient backlog to grow further? Are the Government even considering the impact of uncontrolled virus spread on vulnerable people, the incidence of long covid or the risk of generating yet another variant, with even greater vaccine resistance than delta? Finally, what contingencies are being put in place in case during recess the Government need to reintroduce covid restrictions, as has happened in Israel and the Netherlands?
Nadhim Zahawi
The hon. Lady makes a number of important points, especially the final one, where she reminded the House, as I did in my statement, that a number of countries have opened up and then had to reverse some of their decisions, which is why we are being very careful to ensure that this transition is successful and then that transitioning the virus from pandemic to endemic status is as successful as possible. She asked about children’s vaccination. She will know that the Scottish Health Minister, Humza Yousaf, has accepted, as the Welsh, Northern Irish and ourselves in England have done, the JCVI guidelines on vaccinating vulnerable children, children living with vulnerable adults and those approaching their 18th birthday. If the JCVI goes further, as it is reviewing more data on vaccinating all children, I assure her that we have available the supply of Pfizer and Moderna to undertake that, while we also continue to deliver on the double vaccinations of all adults by the end of September. She asked about the immunosuppressed and of course the guidelines have gone out on the precautionary measures that immunosuppressed people would take; similar to the rest of the country, they should be careful and wear masks in crowded indoor spaces—there is advice on ventilation as well. The JCVI has gone further in its interim advice for our booster campaign, where it has placed the immunosuppressed at the top of the priority list. That campaign will begin in early September—that is the operational target we are working to for beginning boosting and of course co-administering, wherever possible, the flu vaccination.
Mr Alistair Carmichael (Orkney and Shetland) (LD)
Given the massive opposition that there is among those who operate nightclubs and events, the decision of the Government to make the introduction of covid identity cards voluntary is probably a sensible one, but may I explore with the Minister what he means when he says, “We reserve the right to mandate their use in the future”? We might have hoped, Mr Speaker, that the right that the Government sought to reserve was the right to seek the permission of this House to make their use mandatory in the future. I hope that this was just a small piece of ministerial arrogance that led the Minister to mis-speak, but I would like his assurance that we will be given the opportunity to express a view on this before the mandatory use of covid identity cards is introduced.
Last week, I asked the Secretary of State for Health and Social Care a whole range of questions about the practical consequences of this voluntary scheme. I asked what constituted large events, who would be the judge of what they were, what was meant by encouraging businesses, and what would be the consequences for any businesses that resisted the encouragement from the Government. The Secretary of State had no answers to those questions. Will the Minister today answer the questions, if not necessarily for the benefit of the people in this House, then at least with a bit of respect to those who operate nightclubs, big events, restaurants, bars and others who have absolutely no idea what is going to be required of them?
Nadhim Zahawi
It is unlike the right hon. Member for Orkney and Shetland (Mr Carmichael) to accuse any colleague of being arrogant, and I certainly hope that I did not come across as such. He is always courteous and polite—I have certainly found him to be so over the years. He asks several important questions. On reserving the right, the Government will of course come back to the House if the decision is to mandate the double vaccination requirement for nightclubs, crowded unstructured indoor settings, large unstructured outdoor settings and, of course, the very large events such as business, music hall, and spectator sports events. In the meantime, we encourage the use of the NHS covid pass in facilities or at events where people are likely to be in close proximity to large numbers of people from other households. We are working with the sector. Indeed, the Under-Secretary of State for Business, Energy and Industrial Strategy, my hon. Friend the Member for Sutton and Cheam (Paul Scully), met people from the sector yesterday, as he does regularly. The sector itself will have seen what has happened in other countries such as the Netherlands. It is in the interests of all of the sector and of businesses to reopen and reopen permanently, and not have to open and close, open and close, which is why we are working with the sector in this period and giving people a chance to get their double vaccinations by the end of September.
Mr Mark Harper (Forest of Dean) (Con)
Just on that last point about the decision, the statement is very clear that the Government have decided. It says, “We plan to make full vaccination a condition of entry”. My reading of that is that a decision has been taken, so the Government need to come to the House to ask the House’s permission to legislate; the right hon. Member for Orkney and Shetland (Mr Carmichael) was exactly right.
May I ask the Minister about the pingdemic? We have just had the data for last week. More than 600,000 people using the app were told to self-isolate. The Minister has set out clearly that, on 16 August, the right way to proceed is that those who have been double vaccinated will be advised to take a PCR test, and, if that is negative, they can then go about their business, reflecting the reduced risk of their being infected and therefore passing on the disease.
In a discussion this morning on the “Today” programme, the Secretary of State for Business, Energy and Industrial Strategy was told that businesses in a key sector were operating in that way now, with the advice from the app, and he was asked whether that was appropriate and safe. He said that it was not. If it is not safe now—I think it is safe—how does it suddenly become safe on 16 August? Given that it is safe on 16 August, because that is the Government’s policy, can we not just implement it now? The danger is that large numbers of people will either delete or stop listening to the app, and then, when we get to 16 August, they will not be getting the advice to take a PCR test, and we will have actually made ourselves less safe and less well protected. I urge the Minister to think again and to bring it forward now, because people will then be taking tests when they are advised to. If he does not do that, people will simply stop listening, which is very dangerous for public health.
Nadhim Zahawi
I am grateful for my right hon. Friend’s questions, as always: challenging but nevertheless the right challenges to think through. As I said, there are no easy decisions in what we are attempting to do. We will, I hope, be one of the first nations, certainly one of the largest economies in the world, that will see a transition of this virus from pandemic to endemic status—to manageable menace—through our vaccination programme, which is our primary tool.
The second most effective method is to make sure that people do self-isolate: I take on board his point and the point made by my right hon. Friend the Member for South West Surrey (Jeremy Hunt). That is why we are working flat out with critical infrastructure and key workers—of course with frontline NHS and social care staff, as I announced on Monday—to make sure that people have the ability to do a PCR test and then follow it up with a week or up to 10 days of daily lateral flow testing instead of self-isolation for 10 days. The honest truth is that there are no easy answers, because the very clear clinical advice and evidence is that if we do not do this carefully and slowly, we could risk the transition of the virus.
On the requirement around nightclubs by the end of September, I assure my right hon. Friend that we will be coming back to the House to make sure that it has an appropriate say on the matter. As we have seen with this virus in other countries, it is the right thing to do.
Jim Shannon (Strangford) (DUP)
I thank the Minister for his statement and for all that has been done on the covid-19 vaccine roll-out. The Northern Ireland Assembly’s Health Minister recently stated that at the end of July the closure of mass vaccination centres—for example, the SSE centre in Belfast—will come into force. The Minister in this House has today taken the opportunity through the press to urge people one last time to get the vaccine. Has he come to an assessment on the closure of mass vaccination centres in England, given the clear success of the vaccination process, and ever mindful that this autumn we will be doing a covid-19 vaccine booster process, which, along with the flu process, will add pressure to the health system? Will he ensure that there are options in place—for example, pharmacies and community centres—to bridge the gap?
Nadhim Zahawi
I thank the hon. Member for his excellent question. He is absolutely right. We are preparing a pretty ambitious vaccination programme, beginning in early September, for the covid boost. The interim advice from the JCVI could adjust as more clinical data comes through from the cov-boost trials that we are currently conducting. Wherever possible, we will co-administer flu vaccines at large scale. My big concern is that we have not had much flu circulating in communities and we could be in a position where in a bad flu year we could lose 20,000-plus people. Hence our ambitions are equally high for flu. We will look to co-administer wherever possible. We are looking to increase the number of pharmacies as well. We currently have over 600 pharmacies in the covid vaccination infrastructure, as well as the brilliant primary care networks, the hospitals and the vaccination centres. The cov-boost and the flu process will be equally ambitious as we look at the whole of the structure and how we utilise it, as well as making sure that GPs are able to get back to doing the work they need to do—looking after their patients.
Sara Britcliffe (Hyndburn) (Con)
I am seeing in Hyndburn and Haslingden that, as has been mentioned, there is a hesitancy in my age group to take up the vaccine. What work is being done with local authorities to target these groups and alleviate their fears, because the only way out is the vaccine and we really need to get that message across?
Nadhim Zahawi
I am grateful to my hon. Friend for her excellent question and for the work that she does in her constituency to highlight the benefits of being vaccinated—and fully vaccinated. The work that has gone on in Hyndburn is tremendous. We are working with local government to ensure that the NHS has flexibility, whether that is to launch pop-up sites or to increase the hours of vaccination during this period of Eid celebration in order to encourage more of our Muslim fellow citizens to come forward and get vaccinated. Of course, we are ensuring that there is lots of messaging and that people are just pointed to information, including through hyper-local media as well as some of the media with which my hon. Friend’s generation will be more familiar than mine, such as TikTok, social media influencers and YouTubers. That is all happening at scale. It is great to see that the number of appointments booked under the national booking system has almost doubled in the last couple of days, but there are also the walk-in centres, where people can just walk in and get their jab without an appointment.
Neale Hanvey (Kirkcaldy and Cowdenbeath) (Alba)
Mr Speaker, may I add my party’s thanks to you, to the House staff and to everyone across these islands who has worked so hard to save and preserve life during the pandemic?
I want to pick up on a vital component of vaccination that I believe the Government need to give great attention to. It will not have escaped the Minister’s attention, and anyone who has attended the regular briefings that we have had around the virus will have seen in Professor Van-Tam’s heat maps the distribution and upward spread of the virus, whereby it seeds in the younger population and exponentially grows up through the ages.
I really want to ask the Minister why he thinks the JCVI are being extremely cautious in extending vaccination to 12 to 17-year-olds, given that the US Centres for Disease Control and Prevention has now been vaccinating that population in the States—with some concerns, but, I think, manageable numbers of concerns—and why we are not progressing more vigorously to vaccinate that population and are limiting it to those with underlying health concerns or those related to people with underlying health concerns. There is a fundamental advantage to vaccinating this group, because it will increase their wellbeing and improve their access to schooling after their holidays, but, more importantly, it acts as—
Neale Hanvey
I will finish now, Mr Speaker; I apologise.
Does the Minister not see the advantage of delivering those vaccines now, and what do we do if we decide that that needs to go live during the recess?
Nadhim Zahawi
That is a very important question. The JCVI is constantly reviewing the data from other countries that are vaccinating all children of 12 to 15 years old. Its concern has been centred around vaccinating healthy children. There is a very rare signal of myocarditis on first dose. The JCVI is awaiting more data on second dose. It will continue to review that and will come back to us, and, of course, we will come back to the House.
Martin Vickers (Cleethorpes) (Con)
In north-east Lincolnshire, the infection rates has been hovering at around 1,000 per 100,000 for the last couple of weeks, which is of obvious concern to my constituents. I am in regular touch with the Northern Lincolnshire and Goole NHS Foundation Trust, which is doing an excellent job, but could the Minister reassure my constituents that if additional resources are required by the trust, the Department will provide them? The trust has had a big expansion in demand for A&E over the last few days and the trust management asks whether the Department could step up the campaign to encourage people to use the 111 service.
Nadhim Zahawi
My hon. Friend’s constituency of Cleethorpes has now done 122,397 cumulative total of doses, which is a tremendous achievement. I will take away his request and come back to him once I have had the chance to discuss it with NHS England.
Dr Rupa Huq (Ealing Central and Acton) (Lab)
I must thank the Minister for our Friday mornings together. It is not just me; every Member of this House is grateful for that weekly fixture—the highlight Zoom-fest. Is he aware that there are already glitches in the shiny new NHS covid passport that he mentioned? Two of my constituents, Konnie and Charlie, have been going for a year for Novavax trials and now they are being treated as if they are vax deniers, with the texts they get from the NHS, and they are grounded. Another guy, Karl, returned to his native US to have his two jabs because he is not eligible for NHS treatment. He says that it is xenophobia that he cannot access events that Brits can. I am sure it is unintentional. People think that they are being punished for doing the right thing. Will the Minister rectify that?
Nadhim Zahawi
I am really grateful to the hon. Member for that excellent question, and I am grateful for her comments about our Friday morning meetings. Her constituents can rest assured that those who are in clinical trials, including the Novavax trial, will have their data on the NHS covid app as being fully vaccinated, whether they are receiving the placebo or the vaccine, across all trials. That is happening. I will take it offline to look at her constituents’ case to make sure that that happens for them, because I am assured that the system already recognises that.
By the end of this month, UK nationals who have been vaccinated overseas will be able to talk to their GP, go through what vaccine they have had, and have it registered with the NHS that they have been vaccinated. The reason for the conversation with the GP is to make sure that whatever vaccine they have had is approved in the United Kingdom. Ultimately, there will be a co-ordination between the World Health Organisation, ourselves, the European regulator, the US regulator and other regulators around the world. Because we are working at speed, at the moment it is UK nationals and citizens who have had UK vaccinations who will be able to travel to amber list countries other than France and come back and not quarantine. We want to offer the same reciprocity as the 33 countries that recognise our app, and that will also happen very soon.
Mr Philip Hollobone (Kettering) (Con)
I warmly congratulate the Minister for working his socks off over the last year and doing such a tremendous job in vaccinating the nation. In Northamptonshire, the vaccine roll-out has been a tremendous success, with between 90% and 100% of each of the five-year cohorts above age 50 receiving both jabs, and over 67% of 18 to 24-year-olds already having received their first dose. Will the Minister join me in congratulating all the professionals and volunteers locally who have made possible that tremendous local success?
Nadhim Zahawi
I thank my hon. Friend for his work locally and for taking that local leadership, like many colleagues have, to get the message out that vaccines are safe and our way out of this pandemic. Of course I join him in congratulating the whole team—the professionals and the volunteers—on the tremendous effort they have made. The figure I have is 124,042 in the Northamptonshire sustainability and transformation partnership. Its numbers are tremendous; even among 18 to 24-year-olds, it is leading the way, at 67%. We want to get that number even higher as quickly as we can.
John Spellar (Warley) (Lab)
I welcome the Minister’s acknowledgement that the virus is now endemic; indeed, the Government of Singapore have acknowledged that too. Unfortunately, Government dither on that may have scuppered the vaccine pass. Has the Minister had any indication from its diverse opponents of how the country can otherwise take a risk management approach, rather than the risk avoidance approach that has led, for example, to the pingdemic, or the wild west approach advocated by some on his own side, leading to a possible further lockdown? Will he also indicate whether the Treasury is actually engaged in this debate on the side of the economy and public finances—or is it still in Yellow Submarine mode, disappearing under the waves?
Nadhim Zahawi
I am grateful for the right hon. Member’s question. I would just remind him that the Treasury has put £407 billion to work to shelter the economy and people’s livelihoods and, of course, protect jobs. He raises a number of important questions about looking at other countries. As I said earlier, these are all difficult decisions, but I think we are making the right, cautious decision as we transition—I hope—and see this virus move from pandemic to endemic status.
Chris Green (Bolton West) (Con)
Can my right hon. Friend give me a better sense of the scope of how the covid ID card may be used in the future? Would it apply to the London marathon? Would it apply to political gatherings: would someone need an ID card to attend a political gathering, whether supportive of or in opposition to the Government? Could he please rule out its use in educational settings such as sixth-form colleges or universities, which should be excluded? The focus now is on young adults, and the ID card should not be a passport to education or a denial of education.
Nadhim Zahawi
On the last question, I can certainly give my hon. Friend the assurance that in education or in any public buildings this will not be applicable. As to things such as the transport system or essential retail, that is our very strong commitment. Look, I keep repeating this message, but we know what we need to do. Part of what we are learning from the data here and around the world is about trying to work with industries, such as the nightclub industry and sports bodies, to make sure that we reopen fully as safely as possible and continue to be open. The worst thing for any industry or for any sport is to open and then, sadly, to have to shut down again, as people have seen around the world.
Owen Thompson (Midlothian) (SNP)
I listened very carefully to the Minister when he was saying that, for events where large numbers are likely to gather together and be mixing with people from outside their own household, deploying the pass would be the right thing to do. Given that, and to ensure that we keep in step with the public, do the Government intend that to apply here? Might they even reserve the right to mandate the adoption of the pass in this place, or is this another example of us and them?
Nadhim Zahawi
I am grateful for the hon. Member’s question. As I said in answer to the previous question, in public buildings such as this place, and of course in essential travel and essential retail, that will not be applicable. That is very clear.
Dr Andrew Murrison (South West Wiltshire) (Con) [V]
Some 22,000 people died from seasonal flu in 2017-18, and the modelling suggests that this year’s season will start early, be severe and affect younger people—a demographic that tends to go to mass events—than covid does. Have the Government also been considering mandating proof of flu vaccination, and can the Minister ensure that vaccination records are transportable between the NHS records of each of the home nations? That is not the case at the moment, to the huge frustration of those seeking second jabs or anticipating the need for the proof of vaccination that he has confirmed today.
Nadhim Zahawi
I am grateful for my right hon. Friend’s question, and for what he has done during this pandemic in vaccinating and protecting people and helping with the covid vaccination programme. He raises an important question about flu, which I addressed earlier. I am concerned about the flu season, which is why we are being ambitious and looking to co-administer wherever possible. The operational plan is to go early—in early September—for both the covid boost and the flu campaign. However, he will know that flu is not in the covid category in that it is endemic. We are hoping to transition covid towards where flu is with an annual vaccination programme, but it is a very different virus to deal with.
Barbara Keeley (Worsley and Eccles South) (Lab) [V]
On the vaccine roll-out, I would like to ask for the prioritisation of two groups. First, can unpaid carers be prioritised for boosters in the autumn? The JCVI has not put them on the priority list, but they were put in cohort 6 for earlier vaccines. Secondly, can I join my hon. Friend the Member for Ealing Central and Acton (Dr Huq) in asking for a solution to be found for the wonderful volunteers on the Novavax vaccine trial? They now find themselves not able to travel as they cannot get a vaccine certificate and their vaccines are not recognised in the EU. Will the Minister prioritise boosters for unpaid carers to ensure that they are fully protected this autumn? Will he also enable those trialists who have received live Novavax vaccines to have vaccine certificates?
Nadhim Zahawi
I am grateful for the hon. Member’s question. The Novavax trial participants will have their vaccine pass in the United Kingdom. We are working with other countries to make sure that that is recognised, but as far as the UK is concerned, they will be considered fully vaccinated, whether they have had the placebo or the vaccine. On her very good question on the booster campaign, the JCVI’s interim advice is that phase 1 should be the old categories 1 to 4, plus the immuno-suppressed, and phase 2 should be categories 5 to 9, which include unpaid carers in category 6.
Mr Speaker
Order. May I just say to everybody who is left, if we are short and quick on answers and questions, I will get everyone in? We are due to finish now, but I will give it a try.
Jason McCartney (Colne Valley) (Con) [V]
Will the Minister join me in thanking Sylvia, Fahad and all the fantastic local team who have vaccinated more than 47,000 people in Honley, Slaithwaite and other pop-up sites across Kirklees? Can he respond to one of the questions they are regularly being asked, which is about the rationale of the JCVI guidance that there should be an eight-week minimum interval between jabs?
Nadhim Zahawi
I certainly join my hon. Friend in thanking Sylvia, Fahad and all the local team on the extraordinary work they have done. The JCVI advice on the eight-week interval is based on real-world data that suggests that it offers the highest level of protection in terms of antibodies and T cells. Anything below that—I know a number of colleagues have asked me this question—would not be advisable.
Vicky Foxcroft (Lewisham, Deptford) (Lab) [V]
Ministers should be aware of the fears of immuno-compromised people. Unlike the Health Secretary, I know that the Minister is aware of the OCTAVE study. Does he know when it will be published? Can we have some plans for antibody testing? Immuno-compromised people need to be allowed to make informed decisions. Has a ministerial directive been issued to the JCVI to investigate that? If people are seen to have low protection, what extra support are the Government looking to deliver for them?
Nadhim Zahawi
I am grateful for the hon. Member’s questions. She knows—she and I discussed this on Friday morning—that there is OCTAVE and OCTAVE DUO as well. I know that OCTAVE is to report imminently, and I will share that data with colleagues on our group even when the House is in recess. I will make sure that happens as soon as we receive that data. We want to make sure that people are protected. There was some very encouraging data from Public Health England on the immuno-compromised, with 74% production for some, not all, after two doses, but the hon. Member is quite right to point this out. We will look to vaccinate and protect them with a third dose—a booster dose—as the top of group 1 in phase 1 in September.
Richard Graham (Gloucester) (Con) [V]
Nobody underestimates the huge challenges the Government face or the great success of the vaccination programme, but does the Minister recognise the frustration of the many hundreds of thousands who have been double-dosed but are pinged and self-isolating—following the guidelines— when they learn of the data suggesting how many people are turning off or deleting the NHS app, with Ministers reportedly advising businesses that this is only guidance? Does he not share my view that surely what is right on 16 August for the double-dosed is right now? Will he agree to consider implementing the measure as soon as possible so that businesses do not have to close, the hospitality sector does not suffer, and many of us do not self-isolate unnecessarily?
Nadhim Zahawi
My hon. Friend makes a very powerful point that he has made to me many times. It is important clinical guidance to people. It is important that people take personal and corporate responsibility, as we are seeing with some great companies, such as Lidl, which are coming under pressure at the moment because staff are having to self-isolate. As I said earlier, there are no easy decisions on this, but to be able to transition the virus from pandemic to endemic, we just need that careful, little bit more time until 16 August—it is not long to go—when everyone who is double-dosed will not have to self-isolate for 10 days.
Bill Esterson (Sefton Central) (Lab) [V]
We all know that a negative test is a crucial risk indicator. NHS staff are off work, restaurants and pubs are being forced to close, and there are empty supermarket shelves. This is a time-critical problem in essential parts of society, so when are the Government going to publish a list of sectors where staff can use a negative test result so that they can go to work now? Making employers apply for an exemption is simply not going to be enough, and the economy and society simply cannot wait until 16 August.
Nadhim Zahawi
In the interests of time, I should say that I have addressed this question fully. Suffice it to say that I gently disagree with the hon. Member in that society came together, as we saw with the vaccination programme, with 80,000 vaccinator volunteers and 200,000 other volunteers. People are doing the right thing, as are corporates. We are working flat out in terms of the critical workforce, critical infrastructure and the frontline, and we announced on Monday that this would apply also to NHS and social care staff.
Sir David Amess (Southend West) (Con)
I applaud the vaccination programme, but a number of my constituents have received the AstraZeneca vaccine from batches made in India, which is not recognised by the European Medical Agency. Will my hon. Friend reassure those constituents that they will be able to travel to Europe—to France and Italy, for instance?
Nadhim Zahawi
I am grateful to my hon. Friend for his championing of his constituents’ concerns. He is absolutely right to raise them, although I would say to him that the European regulator recognises all AstraZeneca Oxford vaccinations in the United Kingdom and recognises our pass. France has now issued clear guidance that it recognises all batches of the AstraZeneca Oxford vaccine, as well as most of the rest of Europe, and our regulator and the EMA are working with the Italian authorities to get that right. Suffice it to say that I also had a vaccine from one of those batches and it is an excellent vaccine.
Charlotte Nichols (Warrington North) (Lab) [V]
Today it was announced that Australia and New Zealand have withdrawn from autumn’s rugby league world cup, which we are proud to be hosting, citing safety concerns given the shambolic pandemic response by the UK Government. The New Zealand rugby league chief executive has said:
“The tournament organisers have moved heaven and earth to make this work, so it is not an easy decision, but the Covid-19 situation in the UK shows no sign of improving, and it’s simply too unsafe to send teams and staff over.”
Will the Minister therefore commit to meet rugby league MPs and officials to ensure that a safe and competitive tournament can take place with appropriate measures to protect and reassure team and fans alike?
Mr Speaker
Just for the record, I am meeting the rugby league chief executive in an hour’s time.
Nadhim Zahawi
I am grateful to you, Mr Speaker. I know that this is something that you focus on and that is important to you and your constituents. I will happily do the same and meet them, and bring the relevant officials to ensure that we reassure them as well.
Simon Baynes (Clwyd South) (Con)
Will the Minister join me in thanking the many scientists and staff involved in developing and producing the covid vaccines in the UK, including the Wockhardt employees in my constituency, as their achievements have been truly world-beating and remarkable?
Nadhim Zahawi
I am grateful to my hon. Friend and I would certainly join him in congratulating Dame Sarah Gilbert and her team and, of course, the team at Wockhardt, whom I know the Prime Minister has also visited and thanked on behalf of the whole nation.
Steve McCabe (Birmingham, Selly Oak) (Lab) [V]
Further to the question from the hon. Member for Southend West (Sir David Amess), what does the Minister suggest that a constituent of mine who has had the Indian-manufactured Covishield jab should do if they are planning to travel to Portugal or Italy in the next two weeks?
Nadhim Zahawi
The MHRA, our regulator the EMA and, of course, officials are working with the Commission. Wherever we spot these inaccuracies we address them—we have addressed them with Malta and now France. I am assured, as of last night, that pretty much the whole of Europe, other than the Italian authorities—which we are working with—will accept the AstraZeneca vaccine from any batch, because all batches, all factories, are approved by our regulator before they enter the United Kingdom.
Steve Brine (Winchester) (Con)
Today you could go to the Latitude Festival with a negative test or two jabs, and you could go to the open golf last weekend with the same, yet you cannot report for work in the NHS or put food on supermarket shelves. We are rightly worried about the 3 million healthy 18 to 30-year-olds who have yet to get a vaccine, but let us put ourselves in their shoes: they see us all get a jab and wonder what they get in return. So I ask the Minister: do we believe in our vaccine or not, and what is the scientific evidence to explain the difference between 19 July and 16 August when it comes to isolation for the double jab?
Nadhim Zahawi
I thank my hon. Friend, who always asks important yet challenging questions. The 18-year-olds can now look forward to travelling to 33 countries that have accepted double-jabbed Brits who can demonstrate that. If they have their jab now, they can go to those countries from mid-September. They can look forward to clubbing by the end of September as well—enjoying the Winchester nightlife. I hope I have made it clear to the House that giving ourselves that additional few weeks, given that self-isolation is probably the second most effective tool after vaccines, makes a huge difference as we transition this virus. It is not easy, but I certainly think we are doing the right thing by giving ourselves the space and time to transition this virus from pandemic to endemic status.
Mrs Emma Lewell-Buck (South Shields) (Lab)
The app forcing self-isolation is making our country grind to a halt. Delivery drivers, shops, transport, hospitality, factories, and essential public and blue-light services are at breaking point. The Minister has said that there will be no more exemptions to self-isolating. The Business Secretary said the same just this morning. Then, just over an hour ago, he told the press—not this House—that he had changed his mind. Who are we to believe—this Minister or the Business Secretary?
Nadhim Zahawi
I think the hon. Lady has just demonstrated how difficult these decisions are. I would just say to her that we are working flat out, in the Department of Health and Social Care and the Department for Business, Energy and Industrial Strategy, to work with business—whether it is the critical infrastructure that the Business Secretary spoke about, or any other part of the economy—so that we can safely return to a place where we open up, and open up permanently.
Jacob Young (Redcar) (Con)
Redcar and Cleveland had the highest covid rates in the country, at more than 1,500 per 100,000, yet in the past 28 days we have not seen a single death from covid, such is the protection provided by the vaccine. We need more people to get the jab to ensure that our hospitalisations and deaths stay low, so will the Minister work with me and Redcar and Cleveland Borough Council to ensure that we have the additional centres, supplies and vaccinators? Also, will he consider the chemical industry as part of our critical infrastructure, producing the pharmaceuticals for vaccines and the plastics for syringes, for exemption from the usual isolation rules, ahead of 16 August?
Nadhim Zahawi
I am grateful to my hon. Friend for his championing of his businesses and his constituents. There is no shortage of the vaccine. I will happily work with him on the workforce and making sure that there is the resource to make it possible to continue to vaccinate at scale; and of course the industries that are delivering some of the essential products for the vaccination programme are incredibly important in that effort.
Chris Stephens (Glasgow South West) (SNP)
In order to beat this virus, the Government must take care of not only their domestic responsibilities but their international ones. Will the Minister update us on what is being done to ensure vaccine supply to middle-income and lower-income countries, and update us on the international approach?
Nadhim Zahawi
I am grateful to the hon. Member for his excellent question. It is incredibly important, because we pledged to deliver 100 million excess doses, beginning with 5 million immediately and 20 million by the end of the year, and then the balance next year, as well as the Oxford-AstraZeneca vaccine being delivered around the world at no profit to AstraZeneca or Oxford. To update him, we have sent out our first deliveries of the Oxford-AstraZeneca vaccine, as per the Prime Minister’s pledge, and speaking to the Serum Institute of India, they are now not producing 100 million doses a month of that vaccine but are up at 200 million doses a month. It really is an extraordinary achievement by Sarah Gilbert and her team and AstraZeneca in saving the world from this awful virus.
Jonathan Gullis (Stoke-on-Trent North) (Con)
We were very grateful to the Minister for helping us to secure the Tunstall mass vaccination centre, which has delivered over 50,000 jabs into the arms of people and is the city of Stoke-on-Trent’s mass vaccination centre. As part of the autumn roll-out, when we will be getting a third dose into the arms of many residents, will the Minister confirm that the Tunstall mass vaccination centre will stay in place over the autumn and winter this year?
Nadhim Zahawi
I thank my hon. Friend for his effort in getting 116,657 jabs into the arms of his constituents and offering them that protection. I will certainly have a look at the vaccination centre as part of our infrastructure. We have a very ambitious programme to deliver to about 15 million people in the first phase and, with the second phase, a cumulative 32 million people. So we will be doing that at scale as well as, of course, flu vaccination wherever possible.